Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051410 | 0.00000 | Inf | 0 | 3 | 3 | detoxification of nitrogen compound |
| GO:0070458 | 0.00000 | Inf | 0 | 3 | 3 | cellular detoxification of nitrogen compound |
| GO:0006518 | 0.00000 | 3.00087 | 10 | 27 | 788 | peptide metabolic process |
| GO:1990748 | 0.00000 | 16.73596 | 0 | 6 | 35 | cellular detoxification |
| GO:0018916 | 0.00001 | 240.41958 | 0 | 3 | 4 | nitrobenzene metabolic process |
| GO:0006749 | 0.00001 | 10.91673 | 1 | 7 | 59 | glutathione metabolic process |
| GO:0098754 | 0.00002 | 12.12774 | 1 | 6 | 46 | detoxification |
| GO:0071840 | 0.00002 | 1.67357 | 78 | 110 | 6266 | cellular component organization or biogenesis |
| GO:0032101 | 0.00004 | 2.69209 | 10 | 24 | 770 | regulation of response to external stimulus |
| GO:0048660 | 0.00004 | 5.33371 | 2 | 10 | 163 | regulation of smooth muscle cell proliferation |
| GO:0048659 | 0.00005 | 5.16379 | 2 | 10 | 168 | smooth muscle cell proliferation |
| GO:0009987 | 0.00008 | 1.69128 | 197 | 226 | 15803 | cellular process |
| GO:0042178 | 0.00010 | 20.09211 | 0 | 4 | 20 | xenobiotic catabolic process |
| GO:0016043 | 0.00014 | 1.59293 | 76 | 104 | 6083 | cellular component organization |
| GO:0043932 | 0.00015 | Inf | 0 | 2 | 2 | ossification involved in bone remodeling |
| GO:0043603 | 0.00016 | 2.30478 | 13 | 27 | 1008 | cellular amide metabolic process |
| GO:0044237 | 0.00019 | 1.53638 | 117 | 147 | 9374 | cellular metabolic process |
| GO:0010648 | 0.00021 | 2.11566 | 16 | 32 | 1306 | negative regulation of cell communication |
| GO:0023057 | 0.00022 | 2.10864 | 16 | 32 | 1310 | negative regulation of signaling |
| GO:0009408 | 0.00031 | 5.90185 | 1 | 7 | 103 | response to heat |
| GO:2000145 | 0.00032 | 2.28008 | 12 | 25 | 939 | regulation of cell motility |
| GO:0051239 | 0.00034 | 1.69183 | 40 | 62 | 3248 | regulation of multicellular organismal process |
| GO:0006575 | 0.00035 | 4.43299 | 2 | 9 | 174 | cellular modified amino acid metabolic process |
| GO:0070373 | 0.00035 | 7.02166 | 1 | 6 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0030334 | 0.00036 | 2.30098 | 11 | 24 | 892 | regulation of cell migration |
| GO:0009968 | 0.00037 | 2.11933 | 15 | 29 | 1175 | negative regulation of signal transduction |
| GO:0090204 | 0.00046 | 159.72125 | 0 | 2 | 3 | protein localization to nuclear pore |
| GO:0030335 | 0.00046 | 2.68187 | 7 | 17 | 539 | positive regulation of cell migration |
| GO:0007292 | 0.00048 | 4.73471 | 2 | 8 | 145 | female gamete generation |
| GO:0015833 | 0.00049 | 1.87795 | 22 | 39 | 1797 | peptide transport |
| GO:0045899 | 0.00050 | 24.03252 | 0 | 3 | 13 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly |
| GO:0048662 | 0.00051 | 8.38945 | 1 | 5 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:1904705 | 0.00051 | 8.38945 | 1 | 5 | 53 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.00051 | 8.38945 | 1 | 5 | 53 | vascular smooth muscle cell proliferation |
| GO:0051270 | 0.00052 | 2.16257 | 13 | 26 | 1028 | regulation of cellular component movement |
| GO:0051240 | 0.00053 | 1.84175 | 24 | 41 | 1929 | positive regulation of multicellular organismal process |
| GO:0006979 | 0.00053 | 2.97211 | 5 | 14 | 400 | response to oxidative stress |
| GO:0044085 | 0.00056 | 1.67820 | 38 | 58 | 3041 | cellular component biogenesis |
| GO:0042886 | 0.00060 | 1.85507 | 23 | 39 | 1817 | amide transport |
| GO:0071705 | 0.00061 | 1.79093 | 27 | 44 | 2133 | nitrogen compound transport |
| GO:0048585 | 0.00065 | 1.91179 | 20 | 35 | 1576 | negative regulation of response to stimulus |
| GO:0008152 | 0.00070 | 1.47087 | 131 | 158 | 10485 | metabolic process |
| GO:2000147 | 0.00072 | 2.57089 | 7 | 17 | 561 | positive regulation of cell motility |
| GO:0033002 | 0.00074 | 3.63175 | 3 | 10 | 234 | muscle cell proliferation |
| GO:0045664 | 0.00077 | 2.30051 | 10 | 21 | 776 | regulation of neuron differentiation |
| GO:1904395 | 0.00091 | 79.85714 | 0 | 2 | 4 | positive regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:0045898 | 0.00095 | 18.48413 | 0 | 3 | 16 | regulation of RNA polymerase II transcriptional preinitiation complex assembly |
| GO:1902532 | 0.00101 | 2.57027 | 7 | 16 | 527 | negative regulation of intracellular signal transduction |
| GO:0040012 | 0.00101 | 2.09115 | 13 | 25 | 1018 | regulation of locomotion |
| GO:1905209 | 0.00101 | 10.03904 | 0 | 4 | 36 | positive regulation of cardiocyte differentiation |
| GO:0009966 | 0.00102 | 1.66303 | 35 | 53 | 2780 | regulation of signal transduction |
| GO:0071375 | 0.00102 | 3.47502 | 3 | 10 | 244 | cellular response to peptide hormone stimulus |
| GO:0014909 | 0.00103 | 5.62947 | 1 | 6 | 92 | smooth muscle cell migration |
| GO:0009266 | 0.00103 | 4.18156 | 2 | 8 | 163 | response to temperature stimulus |
| GO:0051272 | 0.00104 | 2.48202 | 7 | 17 | 580 | positive regulation of cellular component movement |
| GO:0006807 | 0.00111 | 1.45005 | 111 | 137 | 8923 | nitrogen compound metabolic process |
| GO:0070059 | 0.00113 | 6.93996 | 1 | 5 | 63 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0031347 | 0.00119 | 2.38121 | 8 | 18 | 640 | regulation of defense response |
| GO:0043933 | 0.00129 | 1.76112 | 24 | 40 | 1956 | protein-containing complex subunit organization |
| GO:0040017 | 0.00132 | 2.42459 | 7 | 17 | 593 | positive regulation of locomotion |
| GO:0009636 | 0.00135 | 2.94754 | 4 | 12 | 344 | response to toxic substance |
| GO:0097237 | 0.00135 | 3.99965 | 2 | 8 | 170 | cellular response to toxic substance |
| GO:0060251 | 0.00137 | 9.17734 | 0 | 4 | 39 | regulation of glial cell proliferation |
| GO:0006950 | 0.00140 | 1.57029 | 45 | 65 | 3640 | response to stress |
| GO:0043409 | 0.00140 | 3.97494 | 2 | 8 | 171 | negative regulation of MAPK cascade |
| GO:0051962 | 0.00144 | 2.33868 | 8 | 18 | 651 | positive regulation of nervous system development |
| GO:0045598 | 0.00154 | 4.42019 | 2 | 7 | 135 | regulation of fat cell differentiation |
| GO:0071605 | 0.00160 | 15.01639 | 0 | 3 | 19 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.00160 | 15.01639 | 0 | 3 | 19 | regulation of monocyte chemotactic protein-1 production |
| GO:0007169 | 0.00165 | 2.44298 | 7 | 16 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0003298 | 0.00166 | 8.68051 | 1 | 4 | 41 | physiological muscle hypertrophy |
| GO:0003301 | 0.00166 | 8.68051 | 1 | 4 | 41 | physiological cardiac muscle hypertrophy |
| GO:0061049 | 0.00166 | 8.68051 | 1 | 4 | 41 | cell growth involved in cardiac muscle cell development |
| GO:2001258 | 0.00166 | 8.68051 | 1 | 4 | 41 | negative regulation of cation channel activity |
| GO:0045184 | 0.00168 | 1.75736 | 23 | 38 | 1856 | establishment of protein localization |
| GO:0065003 | 0.00168 | 1.78416 | 22 | 36 | 1729 | protein-containing complex assembly |
| GO:0050727 | 0.00172 | 2.86009 | 4 | 12 | 354 | regulation of inflammatory response |
| GO:0010657 | 0.00184 | 4.98867 | 1 | 6 | 103 | muscle cell apoptotic process |
| GO:0006412 | 0.00190 | 2.33710 | 8 | 17 | 614 | translation |
| GO:0032413 | 0.00193 | 6.09662 | 1 | 5 | 71 | negative regulation of ion transmembrane transporter activity |
| GO:0015031 | 0.00199 | 1.76501 | 22 | 36 | 1746 | protein transport |
| GO:0051960 | 0.00202 | 1.98040 | 13 | 25 | 1071 | regulation of nervous system development |
| GO:0050767 | 0.00208 | 2.03775 | 12 | 23 | 956 | regulation of neurogenesis |
| GO:0014812 | 0.00213 | 4.83837 | 1 | 6 | 106 | muscle cell migration |
| GO:0022607 | 0.00214 | 1.60603 | 35 | 52 | 2807 | cellular component assembly |
| GO:0019083 | 0.00216 | 8.02842 | 1 | 4 | 44 | viral transcription |
| GO:0070093 | 0.00224 | 39.92509 | 0 | 2 | 6 | negative regulation of glucagon secretion |
| GO:1904398 | 0.00224 | 39.92509 | 0 | 2 | 6 | positive regulation of neuromuscular junction development |
| GO:0051050 | 0.00228 | 1.96075 | 13 | 25 | 1081 | positive regulation of transport |
| GO:0031175 | 0.00234 | 1.95686 | 13 | 25 | 1083 | neuron projection development |
| GO:0008285 | 0.00234 | 2.22985 | 8 | 18 | 681 | negative regulation of cell proliferation |
| GO:0042537 | 0.00247 | 12.64372 | 0 | 3 | 22 | benzene-containing compound metabolic process |
| GO:0006874 | 0.00259 | 2.49133 | 6 | 14 | 473 | cellular calcium ion homeostasis |
| GO:1902531 | 0.00259 | 1.74782 | 21 | 35 | 1710 | regulation of intracellular signal transduction |
| GO:0043434 | 0.00261 | 2.85802 | 4 | 11 | 324 | response to peptide hormone |
| GO:0006816 | 0.00264 | 2.58610 | 5 | 13 | 423 | calcium ion transport |
| GO:0042127 | 0.00265 | 1.75901 | 21 | 34 | 1649 | regulation of cell proliferation |
| GO:0007517 | 0.00270 | 2.57969 | 5 | 13 | 424 | muscle organ development |
| GO:0043043 | 0.00274 | 2.25182 | 8 | 17 | 636 | peptide biosynthetic process |
| GO:0045595 | 0.00274 | 1.70329 | 24 | 38 | 1909 | regulation of cell differentiation |
| GO:0043170 | 0.00278 | 1.40455 | 106 | 129 | 8488 | macromolecule metabolic process |
| GO:0010467 | 0.00280 | 1.47054 | 60 | 80 | 4814 | gene expression |
| GO:0006805 | 0.00281 | 4.56330 | 1 | 6 | 112 | xenobiotic metabolic process |
| GO:0060261 | 0.00281 | 12.01101 | 0 | 3 | 23 | positive regulation of transcription initiation from RNA polymerase II promoter |
| GO:0090087 | 0.00282 | 2.13916 | 9 | 19 | 749 | regulation of peptide transport |
| GO:1904019 | 0.00294 | 4.52046 | 1 | 6 | 113 | epithelial cell apoptotic process |
| GO:0034976 | 0.00301 | 3.19920 | 3 | 9 | 237 | response to endoplasmic reticulum stress |
| GO:0051234 | 0.00302 | 1.47609 | 57 | 76 | 4538 | establishment of localization |
| GO:0010646 | 0.00308 | 1.53663 | 42 | 59 | 3338 | regulation of cell communication |
| GO:0006621 | 0.00311 | 31.93868 | 0 | 2 | 7 | protein retention in ER lumen |
| GO:0045048 | 0.00311 | 31.93868 | 0 | 2 | 7 | protein insertion into ER membrane |
| GO:0060510 | 0.00311 | 31.93868 | 0 | 2 | 7 | type II pneumocyte differentiation |
| GO:0071638 | 0.00311 | 31.93868 | 0 | 2 | 7 | negative regulation of monocyte chemotactic protein-1 production |
| GO:0001503 | 0.00313 | 2.64765 | 5 | 12 | 381 | ossification |
| GO:0061061 | 0.00318 | 2.16261 | 9 | 18 | 701 | muscle structure development |
| GO:0090257 | 0.00318 | 3.17110 | 3 | 9 | 239 | regulation of muscle system process |
| GO:0030728 | 0.00319 | 11.43856 | 0 | 3 | 24 | ovulation |
| GO:2001023 | 0.00321 | 4.43713 | 1 | 6 | 115 | regulation of response to drug |
| GO:0032410 | 0.00325 | 5.36291 | 1 | 5 | 80 | negative regulation of transporter activity |
| GO:1901653 | 0.00335 | 2.93001 | 4 | 10 | 287 | cellular response to peptide |
| GO:0048518 | 0.00337 | 1.42344 | 77 | 98 | 6171 | positive regulation of biological process |
| GO:0055074 | 0.00348 | 2.40570 | 6 | 14 | 489 | calcium ion homeostasis |
| GO:0023051 | 0.00356 | 1.52468 | 42 | 59 | 3360 | regulation of signaling |
| GO:0051205 | 0.00359 | 10.91815 | 0 | 3 | 25 | protein insertion into membrane |
| GO:0044267 | 0.00361 | 1.46344 | 57 | 76 | 4569 | cellular protein metabolic process |
| GO:0000302 | 0.00382 | 3.35265 | 3 | 8 | 201 | response to reactive oxygen species |
| GO:0010975 | 0.00388 | 2.22990 | 8 | 16 | 603 | regulation of neuron projection development |
| GO:0072503 | 0.00401 | 2.36501 | 6 | 14 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0051123 | 0.00402 | 10.44299 | 0 | 3 | 26 | RNA polymerase II preinitiation complex assembly |
| GO:0110095 | 0.00412 | 26.61440 | 0 | 2 | 8 | cellular detoxification of aldehyde |
| GO:1901628 | 0.00412 | 26.61440 | 0 | 2 | 8 | positive regulation of postsynaptic membrane organization |
| GO:1903367 | 0.00412 | 26.61440 | 0 | 2 | 8 | positive regulation of fear response |
| GO:1904393 | 0.00412 | 26.61440 | 0 | 2 | 8 | regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:2000987 | 0.00412 | 26.61440 | 0 | 2 | 8 | positive regulation of behavioral fear response |
| GO:0006611 | 0.00412 | 4.20452 | 2 | 6 | 121 | protein export from nucleus |
| GO:0014910 | 0.00422 | 5.02663 | 1 | 5 | 85 | regulation of smooth muscle cell migration |
| GO:0034641 | 0.00423 | 1.42379 | 69 | 89 | 5547 | cellular nitrogen compound metabolic process |
| GO:0048583 | 0.00432 | 1.48129 | 48 | 66 | 3883 | regulation of response to stimulus |
| GO:0014706 | 0.00437 | 2.42907 | 6 | 13 | 449 | striated muscle tissue development |
| GO:0006888 | 0.00446 | 4.13228 | 2 | 6 | 123 | ER to Golgi vesicle-mediated transport |
| GO:0050849 | 0.00448 | 10.00743 | 0 | 3 | 27 | negative regulation of calcium-mediated signaling |
| GO:2000727 | 0.00448 | 10.00743 | 0 | 3 | 27 | positive regulation of cardiac muscle cell differentiation |
| GO:0014009 | 0.00457 | 6.41993 | 1 | 4 | 54 | glial cell proliferation |
| GO:0045599 | 0.00457 | 6.41993 | 1 | 4 | 54 | negative regulation of fat cell differentiation |
| GO:0055025 | 0.00457 | 6.41993 | 1 | 4 | 54 | positive regulation of cardiac muscle tissue development |
| GO:0019538 | 0.00466 | 1.42314 | 67 | 86 | 5344 | protein metabolic process |
| GO:0006810 | 0.00469 | 1.45312 | 55 | 73 | 4398 | transport |
| GO:0051098 | 0.00488 | 2.49624 | 5 | 12 | 403 | regulation of binding |
| GO:0035914 | 0.00489 | 4.84431 | 1 | 5 | 88 | skeletal muscle cell differentiation |
| GO:0051186 | 0.00494 | 2.30644 | 6 | 14 | 509 | cofactor metabolic process |
| GO:0060765 | 0.00497 | 9.60671 | 0 | 3 | 28 | regulation of androgen receptor signaling pathway |
| GO:0070997 | 0.00507 | 2.48331 | 5 | 12 | 405 | neuron death |
| GO:1904063 | 0.00512 | 4.78643 | 1 | 5 | 89 | negative regulation of cation transmembrane transport |
| GO:0065002 | 0.00520 | 6.17247 | 1 | 4 | 56 | intracellular protein transmembrane transport |
| GO:2000026 | 0.00523 | 1.60293 | 27 | 41 | 2184 | regulation of multicellular organismal development |
| GO:0006290 | 0.00525 | 22.81135 | 0 | 2 | 9 | pyrimidine dimer repair |
| GO:0110096 | 0.00525 | 22.81135 | 0 | 2 | 9 | cellular response to aldehyde |
| GO:1901033 | 0.00525 | 22.81135 | 0 | 2 | 9 | positive regulation of response to reactive oxygen species |
| GO:1903911 | 0.00525 | 22.81135 | 0 | 2 | 9 | positive regulation of receptor clustering |
| GO:0060284 | 0.00529 | 1.85131 | 14 | 24 | 1093 | regulation of cell development |
| GO:0044260 | 0.00549 | 1.38013 | 88 | 109 | 7099 | cellular macromolecule metabolic process |
| GO:0060260 | 0.00549 | 9.23682 | 0 | 3 | 29 | regulation of transcription initiation from RNA polymerase II promoter |
| GO:0019080 | 0.00554 | 6.05574 | 1 | 4 | 57 | viral gene expression |
| GO:0046622 | 0.00554 | 6.05574 | 1 | 4 | 57 | positive regulation of organ growth |
| GO:0071806 | 0.00554 | 6.05574 | 1 | 4 | 57 | protein transmembrane transport |
| GO:0045596 | 0.00561 | 1.99753 | 10 | 19 | 799 | negative regulation of cell differentiation |
| GO:0048666 | 0.00563 | 1.79575 | 15 | 26 | 1222 | neuron development |
| GO:0008283 | 0.00564 | 1.62269 | 25 | 38 | 1994 | cell proliferation |
| GO:0051094 | 0.00575 | 1.70494 | 19 | 31 | 1540 | positive regulation of developmental process |
| GO:0007399 | 0.00585 | 1.57477 | 29 | 43 | 2333 | nervous system development |
| GO:0048699 | 0.00591 | 1.67382 | 21 | 33 | 1672 | generation of neurons |
| GO:0072507 | 0.00602 | 2.25064 | 6 | 14 | 521 | divalent inorganic cation homeostasis |
| GO:0044062 | 0.00605 | 8.89433 | 0 | 3 | 30 | regulation of excretion |
| GO:0051100 | 0.00609 | 3.40265 | 2 | 7 | 173 | negative regulation of binding |
| GO:0070972 | 0.00626 | 5.83502 | 1 | 4 | 59 | protein localization to endoplasmic reticulum |
| GO:0050807 | 0.00636 | 2.83457 | 3 | 9 | 266 | regulation of synapse organization |
| GO:0050769 | 0.00640 | 2.16614 | 7 | 15 | 580 | positive regulation of neurogenesis |
| GO:0051246 | 0.00644 | 1.53072 | 33 | 48 | 2687 | regulation of protein metabolic process |
| GO:0010958 | 0.00651 | 19.95906 | 0 | 2 | 10 | regulation of amino acid import across plasma membrane |
| GO:0035437 | 0.00651 | 19.95906 | 0 | 2 | 10 | maintenance of protein localization in endoplasmic reticulum |
| GO:0090435 | 0.00651 | 19.95906 | 0 | 2 | 10 | protein localization to nuclear envelope |
| GO:0060537 | 0.00656 | 2.30500 | 6 | 13 | 472 | muscle tissue development |
| GO:0070838 | 0.00656 | 2.30500 | 6 | 13 | 472 | divalent metal ion transport |
| GO:1903532 | 0.00656 | 2.30500 | 6 | 13 | 472 | positive regulation of secretion by cell |
| GO:2000144 | 0.00664 | 8.57630 | 0 | 3 | 31 | positive regulation of DNA-templated transcription, initiation |
| GO:0051047 | 0.00664 | 2.22372 | 7 | 14 | 527 | positive regulation of secretion |
| GO:1901214 | 0.00671 | 2.50090 | 5 | 11 | 368 | regulation of neuron death |
| GO:0051928 | 0.00673 | 3.77534 | 2 | 6 | 134 | positive regulation of calcium ion transport |
| GO:0030182 | 0.00678 | 1.69765 | 19 | 30 | 1494 | neuron differentiation |
| GO:0072511 | 0.00691 | 2.28972 | 6 | 13 | 475 | divalent inorganic cation transport |
| GO:0051168 | 0.00698 | 3.74591 | 2 | 6 | 135 | nuclear export |
| GO:0032268 | 0.00702 | 1.54168 | 31 | 45 | 2494 | regulation of cellular protein metabolic process |
| GO:1905207 | 0.00704 | 5.62979 | 1 | 4 | 61 | regulation of cardiocyte differentiation |
| GO:0051924 | 0.00731 | 2.76917 | 3 | 9 | 272 | regulation of calcium ion transport |
| GO:0043502 | 0.00735 | 4.36868 | 1 | 5 | 97 | regulation of muscle adaptation |
| GO:0033554 | 0.00736 | 1.63424 | 22 | 34 | 1763 | cellular response to stress |
| GO:0043270 | 0.00740 | 2.59730 | 4 | 10 | 322 | positive regulation of ion transport |
| GO:0010658 | 0.00746 | 5.53249 | 1 | 4 | 62 | striated muscle cell apoptotic process |
| GO:0014911 | 0.00746 | 5.53249 | 1 | 4 | 62 | positive regulation of smooth muscle cell migration |
| GO:0032502 | 0.00748 | 1.37434 | 78 | 97 | 6258 | developmental process |
| GO:0070371 | 0.00756 | 2.58889 | 4 | 10 | 323 | ERK1 and ERK2 cascade |
| GO:0071702 | 0.00758 | 1.53396 | 31 | 45 | 2505 | organic substance transport |
| GO:0010660 | 0.00766 | 4.32152 | 1 | 5 | 98 | regulation of muscle cell apoptotic process |
| GO:0016055 | 0.00774 | 2.34362 | 5 | 12 | 428 | Wnt signaling pathway |
| GO:0044092 | 0.00780 | 1.83693 | 13 | 22 | 1006 | negative regulation of molecular function |
| GO:0042246 | 0.00789 | 5.43848 | 1 | 4 | 63 | tissue regeneration |
| GO:1902260 | 0.00789 | 17.74061 | 0 | 2 | 11 | negative regulation of delayed rectifier potassium channel activity |
| GO:1903365 | 0.00789 | 17.74061 | 0 | 2 | 11 | regulation of fear response |
| GO:2000822 | 0.00789 | 17.74061 | 0 | 2 | 11 | regulation of behavioral fear response |
| GO:0048566 | 0.00791 | 8.00385 | 0 | 3 | 33 | embryonic digestive tract development |
| GO:0070897 | 0.00791 | 8.00385 | 0 | 3 | 33 | transcription preinitiation complex assembly |
| GO:1903205 | 0.00791 | 8.00385 | 0 | 3 | 33 | regulation of hydrogen peroxide-induced cell death |
| GO:0050803 | 0.00801 | 2.72721 | 3 | 9 | 276 | regulation of synapse structure or activity |
| GO:0198738 | 0.00801 | 2.33220 | 5 | 12 | 430 | cell-cell signaling by wnt |
| GO:0050793 | 0.00810 | 1.50872 | 34 | 48 | 2721 | regulation of developmental process |
| GO:2001235 | 0.00819 | 3.20791 | 2 | 7 | 183 | positive regulation of apoptotic signaling pathway |
| GO:0007167 | 0.00828 | 1.88446 | 11 | 20 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0022008 | 0.00832 | 1.61904 | 22 | 34 | 1778 | neurogenesis |
| GO:0045778 | 0.00833 | 4.23017 | 1 | 5 | 100 | positive regulation of ossification |
| GO:0090322 | 0.00860 | 7.74532 | 0 | 3 | 34 | regulation of superoxide metabolic process |
| GO:0043543 | 0.00862 | 2.89779 | 3 | 8 | 231 | protein acylation |
| GO:0050848 | 0.00867 | 4.18592 | 1 | 5 | 101 | regulation of calcium-mediated signaling |
| GO:0051222 | 0.00874 | 2.30412 | 5 | 12 | 435 | positive regulation of protein transport |
| GO:0010720 | 0.00882 | 2.03059 | 8 | 16 | 659 | positive regulation of cell development |
| GO:0002793 | 0.00889 | 2.52348 | 4 | 10 | 331 | positive regulation of peptide secretion |
| GO:1905477 | 0.00903 | 4.14259 | 1 | 5 | 102 | positive regulation of protein localization to membrane |
| GO:0034764 | 0.00906 | 2.87178 | 3 | 8 | 233 | positive regulation of transmembrane transport |
| GO:1901652 | 0.00908 | 2.39192 | 5 | 11 | 384 | response to peptide |
| GO:0097190 | 0.00924 | 2.07203 | 8 | 15 | 605 | apoptotic signaling pathway |
| GO:0090278 | 0.00927 | 5.17465 | 1 | 4 | 66 | negative regulation of peptide hormone secretion |
| GO:1904707 | 0.00932 | 7.50295 | 0 | 3 | 35 | positive regulation of vascular smooth muscle cell proliferation |
| GO:2001038 | 0.00932 | 7.50295 | 0 | 3 | 35 | regulation of cellular response to drug |
| GO:0080134 | 0.00936 | 1.70007 | 17 | 27 | 1337 | regulation of response to stress |
| GO:0034392 | 0.00939 | 15.96585 | 0 | 2 | 12 | negative regulation of smooth muscle cell apoptotic process |
| GO:0070092 | 0.00939 | 15.96585 | 0 | 2 | 12 | regulation of glucagon secretion |
| GO:1901298 | 0.00939 | 15.96585 | 0 | 2 | 12 | regulation of hydrogen peroxide-mediated programmed cell death |
| GO:1903789 | 0.00939 | 15.96585 | 0 | 2 | 12 | regulation of amino acid transmembrane transport |
| GO:0006801 | 0.00976 | 5.09229 | 1 | 4 | 67 | superoxide metabolic process |
| GO:0030518 | 0.00978 | 4.05854 | 1 | 5 | 104 | intracellular steroid hormone receptor signaling pathway |
| GO:0032102 | 0.00981 | 2.48422 | 4 | 10 | 336 | negative regulation of response to external stimulus |
| GO:0009628 | 0.01009 | 1.79124 | 13 | 22 | 1030 | response to abiotic stimulus |
| GO:0034766 | 0.01016 | 4.01778 | 1 | 5 | 105 | negative regulation of ion transmembrane transport |
| GO:0055017 | 0.01016 | 4.01778 | 1 | 5 | 105 | cardiac muscle tissue growth |
| GO:0045444 | 0.01021 | 2.80873 | 3 | 8 | 238 | fat cell differentiation |
| GO:0045669 | 0.01028 | 5.01250 | 1 | 4 | 68 | positive regulation of osteoblast differentiation |
| GO:0032091 | 0.01056 | 3.97783 | 1 | 5 | 106 | negative regulation of protein binding |
| GO:0048661 | 0.01056 | 3.97783 | 1 | 5 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0045597 | 0.01060 | 1.75887 | 14 | 23 | 1097 | positive regulation of cell differentiation |
| GO:0071495 | 0.01060 | 1.71711 | 15 | 25 | 1223 | cellular response to endogenous stimulus |
| GO:0006913 | 0.01062 | 2.59909 | 4 | 9 | 289 | nucleocytoplasmic transport |
| GO:0051169 | 0.01062 | 2.59909 | 4 | 9 | 289 | nuclear transport |
| GO:0007275 | 0.01068 | 1.36971 | 67 | 84 | 5362 | multicellular organism development |
| GO:0043393 | 0.01070 | 2.78427 | 3 | 8 | 240 | regulation of protein binding |
| GO:0032879 | 0.01079 | 1.47555 | 35 | 49 | 2835 | regulation of localization |
| GO:0043407 | 0.01080 | 4.93517 | 1 | 4 | 69 | negative regulation of MAP kinase activity |
| GO:0006397 | 0.01086 | 2.23413 | 6 | 12 | 448 | mRNA processing |
| GO:0036474 | 0.01086 | 7.06098 | 0 | 3 | 37 | cell death in response to hydrogen peroxide |
| GO:0000165 | 0.01087 | 1.89800 | 10 | 18 | 793 | MAPK cascade |
| GO:0006928 | 0.01099 | 1.55544 | 25 | 37 | 2014 | movement of cell or subcellular component |
| GO:0001542 | 0.01101 | 14.51378 | 0 | 2 | 13 | ovulation from ovarian follicle |
| GO:0006983 | 0.01101 | 14.51378 | 0 | 2 | 13 | ER overload response |
| GO:0032099 | 0.01101 | 14.51378 | 0 | 2 | 13 | negative regulation of appetite |
| GO:0034350 | 0.01101 | 14.51378 | 0 | 2 | 13 | regulation of glial cell apoptotic process |
| GO:0061140 | 0.01101 | 14.51378 | 0 | 2 | 13 | lung secretory cell differentiation |
| GO:0070091 | 0.01101 | 14.51378 | 0 | 2 | 13 | glucagon secretion |
| GO:0070471 | 0.01101 | 14.51378 | 0 | 2 | 13 | uterine smooth muscle contraction |
| GO:0090073 | 0.01101 | 14.51378 | 0 | 2 | 13 | positive regulation of protein homodimerization activity |
| GO:1903817 | 0.01101 | 14.51378 | 0 | 2 | 13 | negative regulation of voltage-gated potassium channel activity |
| GO:1903862 | 0.01101 | 14.51378 | 0 | 2 | 13 | positive regulation of oxidative phosphorylation |
| GO:1904396 | 0.01101 | 14.51378 | 0 | 2 | 13 | regulation of neuromuscular junction development |
| GO:0007611 | 0.01130 | 2.57120 | 4 | 9 | 292 | learning or memory |
| GO:0030111 | 0.01130 | 2.57120 | 4 | 9 | 292 | regulation of Wnt signaling pathway |
| GO:0097193 | 0.01130 | 2.57120 | 4 | 9 | 292 | intrinsic apoptotic signaling pathway |
| GO:0001817 | 0.01149 | 1.96757 | 8 | 16 | 679 | regulation of cytokine production |
| GO:0042326 | 0.01158 | 2.21342 | 6 | 12 | 452 | negative regulation of phosphorylation |
| GO:0072595 | 0.01169 | 6.85894 | 0 | 3 | 38 | maintenance of protein localization in organelle |
| GO:2001025 | 0.01169 | 6.85894 | 0 | 3 | 38 | positive regulation of response to drug |
| GO:1901215 | 0.01174 | 2.73659 | 3 | 8 | 244 | negative regulation of neuron death |
| GO:0032092 | 0.01182 | 3.86257 | 1 | 5 | 109 | positive regulation of protein binding |
| GO:0010611 | 0.01191 | 4.78743 | 1 | 4 | 71 | regulation of cardiac muscle hypertrophy |
| GO:0043604 | 0.01192 | 1.91618 | 9 | 17 | 741 | amide biosynthetic process |
| GO:1904951 | 0.01196 | 2.20321 | 6 | 12 | 454 | positive regulation of establishment of protein localization |
| GO:0007519 | 0.01197 | 2.96971 | 2 | 7 | 197 | skeletal muscle tissue development |
| GO:0000032 | 0.01245 | Inf | 0 | 1 | 1 | cell wall mannoprotein biosynthetic process |
| GO:0002174 | 0.01245 | Inf | 0 | 1 | 1 | mammary stem cell proliferation |
| GO:0003421 | 0.01245 | Inf | 0 | 1 | 1 | growth plate cartilage axis specification |
| GO:0006056 | 0.01245 | Inf | 0 | 1 | 1 | mannoprotein metabolic process |
| GO:0006057 | 0.01245 | Inf | 0 | 1 | 1 | mannoprotein biosynthetic process |
| GO:0006313 | 0.01245 | Inf | 0 | 1 | 1 | transposition, DNA-mediated |
| GO:0018323 | 0.01245 | Inf | 0 | 1 | 1 | enzyme active site formation via L-cysteine sulfinic acid |
| GO:0018900 | 0.01245 | Inf | 0 | 1 | 1 | dichloromethane metabolic process |
| GO:0019309 | 0.01245 | Inf | 0 | 1 | 1 | mannose catabolic process |
| GO:0021501 | 0.01245 | Inf | 0 | 1 | 1 | prechordal plate formation |
| GO:0021547 | 0.01245 | Inf | 0 | 1 | 1 | midbrain-hindbrain boundary initiation |
| GO:0030264 | 0.01245 | Inf | 0 | 1 | 1 | nuclear fragmentation involved in apoptotic nuclear change |
| GO:0031506 | 0.01245 | Inf | 0 | 1 | 1 | cell wall glycoprotein biosynthetic process |
| GO:0034120 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of erythrocyte aggregation |
| GO:0034443 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein oxidation |
| GO:0036031 | 0.01245 | Inf | 0 | 1 | 1 | recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex |
| GO:0036471 | 0.01245 | Inf | 0 | 1 | 1 | cellular response to glyoxal |
| GO:0036525 | 0.01245 | Inf | 0 | 1 | 1 | protein deglycation |
| GO:0036526 | 0.01245 | Inf | 0 | 1 | 1 | peptidyl-cysteine deglycation |
| GO:0036527 | 0.01245 | Inf | 0 | 1 | 1 | peptidyl-arginine deglycation |
| GO:0036528 | 0.01245 | Inf | 0 | 1 | 1 | peptidyl-lysine deglycation |
| GO:0036529 | 0.01245 | Inf | 0 | 1 | 1 | protein deglycation, glyoxal removal |
| GO:0036531 | 0.01245 | Inf | 0 | 1 | 1 | glutathione deglycation |
| GO:0042546 | 0.01245 | Inf | 0 | 1 | 1 | cell wall biogenesis |
| GO:0044038 | 0.01245 | Inf | 0 | 1 | 1 | cell wall macromolecule biosynthetic process |
| GO:0044722 | 0.01245 | Inf | 0 | 1 | 1 | renal phosphate excretion |
| GO:0046295 | 0.01245 | Inf | 0 | 1 | 1 | glycolate biosynthetic process |
| GO:0060588 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein lipid oxidation |
| GO:0061611 | 0.01245 | Inf | 0 | 1 | 1 | mannose to fructose-6-phosphate metabolic process |
| GO:0061619 | 0.01245 | Inf | 0 | 1 | 1 | glycolytic process from mannose through fructose-6-phosphate |
| GO:0070589 | 0.01245 | Inf | 0 | 1 | 1 | cellular component macromolecule biosynthetic process |
| GO:0071109 | 0.01245 | Inf | 0 | 1 | 1 | superior temporal gyrus development |
| GO:0071284 | 0.01245 | Inf | 0 | 1 | 1 | cellular response to lead ion |
| GO:0071707 | 0.01245 | Inf | 0 | 1 | 1 | immunoglobulin heavy chain V-D-J recombination |
| GO:0098038 | 0.01245 | Inf | 0 | 1 | 1 | non-replicative transposition, DNA-mediated |
| GO:0098529 | 0.01245 | Inf | 0 | 1 | 1 | neuromuscular junction development, skeletal muscle fiber |
| GO:0098737 | 0.01245 | Inf | 0 | 1 | 1 | protein insertion into plasma membrane |
| GO:0106005 | 0.01245 | Inf | 0 | 1 | 1 | RNA 5'-cap (guanine-N7)-methylation |
| GO:0106044 | 0.01245 | Inf | 0 | 1 | 1 | guanine deglycation |
| GO:0106045 | 0.01245 | Inf | 0 | 1 | 1 | guanine deglycation, methylglyoxal removal |
| GO:0106046 | 0.01245 | Inf | 0 | 1 | 1 | guanine deglycation, glyoxal removal |
| GO:0120179 | 0.01245 | Inf | 0 | 1 | 1 | adherens junction disassembly |
| GO:0120180 | 0.01245 | Inf | 0 | 1 | 1 | cell-substrate adherens junction disassembly |
| GO:0120181 | 0.01245 | Inf | 0 | 1 | 1 | focal adhesion disassembly |
| GO:0120182 | 0.01245 | Inf | 0 | 1 | 1 | regulation of focal adhesion disassembly |
| GO:0120183 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of focal adhesion disassembly |
| GO:0140041 | 0.01245 | Inf | 0 | 1 | 1 | cellular detoxification of methylglyoxal |
| GO:1901631 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of presynaptic membrane organization |
| GO:1902721 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of prolactin secretion |
| GO:1903122 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1903167 | 0.01245 | Inf | 0 | 1 | 1 | regulation of pyrroline-5-carboxylate reductase activity |
| GO:1903168 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of pyrroline-5-carboxylate reductase activity |
| GO:1903176 | 0.01245 | Inf | 0 | 1 | 1 | regulation of tyrosine 3-monooxygenase activity |
| GO:1903178 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of tyrosine 3-monooxygenase activity |
| GO:1903184 | 0.01245 | Inf | 0 | 1 | 1 | L-dopa metabolic process |
| GO:1903185 | 0.01245 | Inf | 0 | 1 | 1 | L-dopa biosynthetic process |
| GO:1903189 | 0.01245 | Inf | 0 | 1 | 1 | glyoxal metabolic process |
| GO:1903195 | 0.01245 | Inf | 0 | 1 | 1 | regulation of L-dopa biosynthetic process |
| GO:1903197 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of L-dopa biosynthetic process |
| GO:1903198 | 0.01245 | Inf | 0 | 1 | 1 | regulation of L-dopa decarboxylase activity |
| GO:1903200 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of L-dopa decarboxylase activity |
| GO:1903402 | 0.01245 | Inf | 0 | 1 | 1 | regulation of renal phosphate excretion |
| GO:1903403 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:1904073 | 0.01245 | Inf | 0 | 1 | 1 | regulation of trophectodermal cell proliferation |
| GO:1904075 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of trophectodermal cell proliferation |
| GO:1904675 | 0.01245 | Inf | 0 | 1 | 1 | regulation of somatic stem cell division |
| GO:1904677 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of somatic stem cell division |
| GO:1905008 | 0.01245 | Inf | 0 | 1 | 1 | regulation of L-lysine import across plasma membrane |
| GO:1905010 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
| GO:1905541 | 0.01245 | Inf | 0 | 1 | 1 | regulation of L-arginine import across plasma membrane |
| GO:1905589 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
| GO:1905913 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of calcium ion export across plasma membrane |
| GO:2000101 | 0.01245 | Inf | 0 | 1 | 1 | regulation of mammary stem cell proliferation |
| GO:2000103 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of mammary stem cell proliferation |
| GO:2000284 | 0.01245 | Inf | 0 | 1 | 1 | positive regulation of cellular amino acid biosynthetic process |
| GO:2000428 | 0.01245 | Inf | 0 | 1 | 1 | regulation of neutrophil aggregation |
| GO:2000429 | 0.01245 | Inf | 0 | 1 | 1 | negative regulation of neutrophil aggregation |
| GO:1903829 | 0.01252 | 2.52600 | 4 | 9 | 297 | positive regulation of cellular protein localization |
| GO:0010613 | 0.01254 | 6.66812 | 0 | 3 | 39 | positive regulation of cardiac muscle hypertrophy |
| GO:0030521 | 0.01254 | 6.66812 | 0 | 3 | 39 | androgen receptor signaling pathway |
| GO:2000142 | 0.01254 | 6.66812 | 0 | 3 | 39 | regulation of DNA-templated transcription, initiation |
| GO:0045861 | 0.01255 | 2.38758 | 4 | 10 | 349 | negative regulation of proteolysis |
| GO:0043401 | 0.01271 | 3.78936 | 1 | 5 | 111 | steroid hormone mediated signaling pathway |
| GO:0071901 | 0.01271 | 3.78936 | 1 | 5 | 111 | negative regulation of protein serine/threonine kinase activity |
| GO:0010421 | 0.01274 | 13.30372 | 0 | 2 | 14 | hydrogen peroxide-mediated programmed cell death |
| GO:0010642 | 0.01274 | 13.30372 | 0 | 2 | 14 | negative regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0032096 | 0.01274 | 13.30372 | 0 | 2 | 14 | negative regulation of response to food |
| GO:0033690 | 0.01274 | 13.30372 | 0 | 2 | 14 | positive regulation of osteoblast proliferation |
| GO:0071340 | 0.01274 | 13.30372 | 0 | 2 | 14 | skeletal muscle acetylcholine-gated channel clustering |
| GO:0097468 | 0.01274 | 13.30372 | 0 | 2 | 14 | programmed cell death in response to reactive oxygen species |
| GO:0099116 | 0.01274 | 13.30372 | 0 | 2 | 14 | tRNA 5'-end processing |
| GO:1905063 | 0.01274 | 13.30372 | 0 | 2 | 14 | regulation of vascular smooth muscle cell differentiation |
| GO:0046907 | 0.01279 | 1.62408 | 19 | 29 | 1502 | intracellular transport |
| GO:2000377 | 0.01292 | 2.92316 | 2 | 7 | 200 | regulation of reactive oxygen species metabolic process |
| GO:0007005 | 0.01294 | 2.17808 | 6 | 12 | 459 | mitochondrion organization |
| GO:0051145 | 0.01309 | 4.64826 | 1 | 4 | 73 | smooth muscle cell differentiation |
| GO:1990542 | 0.01309 | 4.64826 | 1 | 4 | 73 | mitochondrial transmembrane transport |
| GO:0046822 | 0.01317 | 3.75378 | 1 | 5 | 112 | regulation of nucleocytoplasmic transport |
| GO:0062013 | 0.01323 | 3.24026 | 2 | 6 | 155 | positive regulation of small molecule metabolic process |
| GO:0023014 | 0.01325 | 1.85584 | 10 | 18 | 810 | signal transduction by protein phosphorylation |
| GO:0043065 | 0.01334 | 1.97897 | 8 | 15 | 632 | positive regulation of apoptotic process |
| GO:0045666 | 0.01335 | 2.16819 | 6 | 12 | 461 | positive regulation of neuron differentiation |
| GO:0055114 | 0.01342 | 1.82055 | 11 | 19 | 872 | oxidation-reduction process |
| GO:0014742 | 0.01344 | 6.48762 | 0 | 3 | 40 | positive regulation of muscle hypertrophy |
| GO:0046825 | 0.01344 | 6.48762 | 0 | 3 | 40 | regulation of protein export from nucleus |
| GO:0070884 | 0.01344 | 6.48762 | 0 | 3 | 40 | regulation of calcineurin-NFAT signaling cascade |
| GO:0098801 | 0.01344 | 6.48762 | 0 | 3 | 40 | regulation of renal system process |
| GO:0106056 | 0.01344 | 6.48762 | 0 | 3 | 40 | regulation of calcineurin-mediated signaling |
| GO:0034622 | 0.01349 | 1.76374 | 12 | 21 | 996 | cellular protein-containing complex assembly |
| GO:0032870 | 0.01354 | 2.09074 | 6 | 13 | 518 | cellular response to hormone stimulus |
| GO:0014743 | 0.01370 | 4.58165 | 1 | 4 | 74 | regulation of muscle hypertrophy |
| GO:0001933 | 0.01379 | 2.24493 | 5 | 11 | 408 | negative regulation of protein phosphorylation |
| GO:0050714 | 0.01383 | 2.48235 | 4 | 9 | 302 | positive regulation of protein secretion |
| GO:0016477 | 0.01395 | 1.62560 | 18 | 28 | 1447 | cell migration |
| GO:0071466 | 0.01402 | 3.19706 | 2 | 6 | 157 | cellular response to xenobiotic stimulus |
| GO:0010942 | 0.01405 | 1.91982 | 9 | 16 | 695 | positive regulation of cell death |
| GO:0048856 | 0.01411 | 1.34090 | 73 | 90 | 5871 | anatomical structure development |
| GO:0060419 | 0.01413 | 3.68458 | 1 | 5 | 114 | heart growth |
| GO:0051603 | 0.01423 | 1.91691 | 9 | 16 | 696 | proteolysis involved in cellular protein catabolic process |
| GO:0043068 | 0.01423 | 1.96262 | 8 | 15 | 637 | positive regulation of programmed cell death |
| GO:0046782 | 0.01437 | 6.31662 | 1 | 3 | 41 | regulation of viral transcription |
| GO:0032269 | 0.01449 | 1.75061 | 12 | 21 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0048523 | 0.01454 | 1.36600 | 58 | 74 | 4687 | negative regulation of cellular process |
| GO:0034471 | 0.01458 | 12.27982 | 0 | 2 | 15 | ncRNA 5'-end processing |
| GO:0050930 | 0.01458 | 12.27982 | 0 | 2 | 15 | induction of positive chemotaxis |
| GO:0061051 | 0.01458 | 12.27982 | 0 | 2 | 15 | positive regulation of cell growth involved in cardiac muscle cell development |
| GO:0090197 | 0.01458 | 12.27982 | 0 | 2 | 15 | positive regulation of chemokine secretion |
| GO:0051099 | 0.01462 | 2.84872 | 3 | 7 | 205 | positive regulation of binding |
| GO:0042552 | 0.01484 | 3.15499 | 2 | 6 | 159 | myelination |
| GO:0006875 | 0.01487 | 2.00347 | 7 | 14 | 582 | cellular metal ion homeostasis |
| GO:0070372 | 0.01494 | 2.44848 | 4 | 9 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0006886 | 0.01496 | 1.79864 | 11 | 19 | 882 | intracellular protein transport |
| GO:0030003 | 0.01498 | 1.94973 | 8 | 15 | 641 | cellular cation homeostasis |
| GO:0060538 | 0.01498 | 2.83428 | 3 | 7 | 206 | skeletal muscle organ development |
| GO:0051093 | 0.01509 | 1.71972 | 13 | 22 | 1070 | negative regulation of developmental process |
| GO:0051248 | 0.01509 | 1.71972 | 13 | 22 | 1070 | negative regulation of protein metabolic process |
| GO:0006396 | 0.01517 | 1.82715 | 10 | 18 | 822 | RNA processing |
| GO:2001233 | 0.01521 | 2.21092 | 5 | 11 | 414 | regulation of apoptotic signaling pathway |
| GO:0055023 | 0.01533 | 6.15438 | 1 | 3 | 42 | positive regulation of cardiac muscle tissue growth |
| GO:0043500 | 0.01565 | 3.58542 | 1 | 5 | 117 | muscle adaptation |
| GO:0033108 | 0.01566 | 4.39279 | 1 | 4 | 77 | mitochondrial respiratory chain complex assembly |
| GO:1903050 | 0.01572 | 2.80583 | 3 | 7 | 208 | regulation of proteolysis involved in cellular protein catabolic process |
| GO:0010976 | 0.01582 | 2.29808 | 5 | 10 | 362 | positive regulation of neuron projection development |
| GO:0044238 | 0.01584 | 1.30024 | 118 | 136 | 9443 | primary metabolic process |
| GO:0051172 | 0.01584 | 1.48978 | 28 | 40 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0002791 | 0.01584 | 2.04517 | 7 | 13 | 529 | regulation of peptide secretion |
| GO:0009059 | 0.01605 | 1.37698 | 51 | 66 | 4121 | macromolecule biosynthetic process |
| GO:0019722 | 0.01610 | 2.79182 | 3 | 7 | 209 | calcium-mediated signaling |
| GO:0007272 | 0.01613 | 3.09391 | 2 | 6 | 162 | ensheathment of neurons |
| GO:0008366 | 0.01613 | 3.09391 | 2 | 6 | 162 | axon ensheathment |
| GO:0016070 | 0.01630 | 1.38985 | 47 | 61 | 3761 | RNA metabolic process |
| GO:1901031 | 0.01634 | 6.00026 | 1 | 3 | 43 | regulation of response to reactive oxygen species |
| GO:0051881 | 0.01635 | 4.33324 | 1 | 4 | 78 | regulation of mitochondrial membrane potential |
| GO:0008380 | 0.01638 | 2.28490 | 5 | 10 | 364 | RNA splicing |
| GO:0051223 | 0.01645 | 1.88266 | 9 | 16 | 708 | regulation of protein transport |
| GO:0032105 | 0.01652 | 11.40219 | 0 | 2 | 16 | negative regulation of response to extracellular stimulus |
| GO:0032108 | 0.01652 | 11.40219 | 0 | 2 | 16 | negative regulation of response to nutrient levels |
| GO:0070885 | 0.01652 | 11.40219 | 0 | 2 | 16 | negative regulation of calcineurin-NFAT signaling cascade |
| GO:0090196 | 0.01652 | 11.40219 | 0 | 2 | 16 | regulation of chemokine secretion |
| GO:0097284 | 0.01652 | 11.40219 | 0 | 2 | 16 | hepatocyte apoptotic process |
| GO:0106057 | 0.01652 | 11.40219 | 0 | 2 | 16 | negative regulation of calcineurin-mediated signaling |
| GO:0071704 | 0.01657 | 1.29627 | 125 | 143 | 10008 | organic substance metabolic process |
| GO:1904064 | 0.01658 | 3.07407 | 2 | 6 | 163 | positive regulation of cation transmembrane transport |
| GO:0032103 | 0.01674 | 2.39936 | 4 | 9 | 312 | positive regulation of response to external stimulus |
| GO:0051128 | 0.01685 | 1.45781 | 32 | 44 | 2558 | regulation of cellular component organization |
| GO:0046887 | 0.01703 | 3.05448 | 2 | 6 | 164 | positive regulation of hormone secretion |
| GO:0033143 | 0.01706 | 4.27527 | 1 | 4 | 79 | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:0051781 | 0.01706 | 4.27527 | 1 | 4 | 79 | positive regulation of cell division |
| GO:0120035 | 0.01715 | 1.83493 | 10 | 17 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0002790 | 0.01720 | 1.91511 | 8 | 15 | 652 | peptide secretion |
| GO:0008584 | 0.01728 | 3.49143 | 1 | 5 | 120 | male gonad development |
| GO:0044070 | 0.01728 | 3.49143 | 1 | 5 | 120 | regulation of anion transport |
| GO:0014904 | 0.01737 | 5.85366 | 1 | 3 | 44 | myotube cell development |
| GO:0033365 | 0.01754 | 1.82992 | 10 | 17 | 774 | protein localization to organelle |
| GO:0030163 | 0.01771 | 1.76462 | 11 | 19 | 898 | protein catabolic process |
| GO:0051049 | 0.01779 | 1.51495 | 24 | 35 | 1946 | regulation of transport |
| GO:0006873 | 0.01784 | 1.90588 | 8 | 15 | 655 | cellular ion homeostasis |
| GO:0008286 | 0.01785 | 3.46118 | 2 | 5 | 121 | insulin receptor signaling pathway |
| GO:0046546 | 0.01785 | 3.46118 | 2 | 5 | 121 | development of primary male sexual characteristics |
| GO:0030162 | 0.01807 | 1.86047 | 9 | 16 | 716 | regulation of proteolysis |
| GO:0008406 | 0.01808 | 2.72378 | 3 | 7 | 214 | gonad development |
| GO:0048584 | 0.01839 | 1.47294 | 29 | 40 | 2294 | positive regulation of response to stimulus |
| GO:0010257 | 0.01845 | 5.71404 | 1 | 3 | 45 | NADH dehydrogenase complex assembly |
| GO:0032981 | 0.01845 | 5.71404 | 1 | 3 | 45 | mitochondrial respiratory chain complex I assembly |
| GO:0060421 | 0.01845 | 5.71404 | 1 | 3 | 45 | positive regulation of heart growth |
| GO:1903580 | 0.01845 | 5.71404 | 1 | 3 | 45 | positive regulation of ATP metabolic process |
| GO:0000188 | 0.01858 | 10.64158 | 0 | 2 | 17 | inactivation of MAPK activity |
| GO:0000966 | 0.01858 | 10.64158 | 0 | 2 | 17 | RNA 5'-end processing |
| GO:0034349 | 0.01858 | 10.64158 | 0 | 2 | 17 | glial cell apoptotic process |
| GO:0035988 | 0.01858 | 10.64158 | 0 | 2 | 17 | chondrocyte proliferation |
| GO:0042756 | 0.01858 | 10.64158 | 0 | 2 | 17 | drinking behavior |
| GO:0060253 | 0.01858 | 10.64158 | 0 | 2 | 17 | negative regulation of glial cell proliferation |
| GO:0090195 | 0.01858 | 10.64158 | 0 | 2 | 17 | chemokine secretion |
| GO:0019932 | 0.01867 | 2.14059 | 5 | 11 | 427 | second-messenger-mediated signaling |
| GO:0031344 | 0.01896 | 1.81258 | 10 | 17 | 781 | regulation of cell projection organization |
| GO:0008104 | 0.01903 | 1.44489 | 32 | 44 | 2578 | protein localization |
| GO:0048731 | 0.01918 | 1.34440 | 59 | 74 | 4746 | system development |
| GO:0071363 | 0.01929 | 1.93359 | 7 | 14 | 602 | cellular response to growth factor stimulus |
| GO:0040007 | 0.01947 | 1.67446 | 14 | 22 | 1097 | growth |
| GO:0032456 | 0.01956 | 5.58091 | 1 | 3 | 46 | endocytic recycling |
| GO:0045137 | 0.01979 | 2.67167 | 3 | 7 | 218 | development of primary sexual characteristics |
| GO:0051179 | 0.01982 | 1.31673 | 74 | 90 | 5950 | localization |
| GO:0001558 | 0.01984 | 2.11983 | 5 | 11 | 431 | regulation of cell growth |
| GO:0055065 | 0.01989 | 1.87869 | 8 | 15 | 664 | metal ion homeostasis |
| GO:0010563 | 0.01997 | 1.97844 | 7 | 13 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.01997 | 1.97844 | 7 | 13 | 546 | negative regulation of phosphate metabolic process |
| GO:0051046 | 0.02022 | 1.73788 | 11 | 19 | 911 | regulation of secretion |
| GO:0034645 | 0.02023 | 1.36279 | 50 | 64 | 4022 | cellular macromolecule biosynthetic process |
| GO:0043271 | 0.02047 | 2.92400 | 2 | 6 | 171 | negative regulation of ion transport |
| GO:0048010 | 0.02070 | 5.45383 | 1 | 3 | 47 | vascular endothelial growth factor receptor signaling pathway |
| GO:0006851 | 0.02073 | 9.97605 | 0 | 2 | 18 | mitochondrial calcium ion transmembrane transport |
| GO:1903209 | 0.02073 | 9.97605 | 0 | 2 | 18 | positive regulation of oxidative stress-induced cell death |
| GO:1903909 | 0.02073 | 9.97605 | 0 | 2 | 18 | regulation of receptor clustering |
| GO:1904706 | 0.02073 | 9.97605 | 0 | 2 | 18 | negative regulation of vascular smooth muscle cell proliferation |
| GO:2000846 | 0.02073 | 9.97605 | 0 | 2 | 18 | regulation of corticosteroid hormone secretion |
| GO:0007610 | 0.02073 | 1.82813 | 9 | 16 | 728 | behavior |
| GO:0045844 | 0.02089 | 4.00719 | 1 | 4 | 84 | positive regulation of striated muscle tissue development |
| GO:0048636 | 0.02089 | 4.00719 | 1 | 4 | 84 | positive regulation of muscle organ development |
| GO:0006790 | 0.02114 | 2.44333 | 3 | 8 | 272 | sulfur compound metabolic process |
| GO:0034504 | 0.02114 | 2.44333 | 3 | 8 | 272 | protein localization to nucleus |
| GO:0050890 | 0.02155 | 2.29198 | 4 | 9 | 326 | cognition |
| GO:0043269 | 0.02168 | 1.81759 | 9 | 16 | 732 | regulation of ion transport |
| GO:0055080 | 0.02168 | 1.81759 | 9 | 16 | 732 | cation homeostasis |
| GO:0051341 | 0.02171 | 3.95755 | 1 | 4 | 85 | regulation of oxidoreductase activity |
| GO:1901863 | 0.02171 | 3.95755 | 1 | 4 | 85 | positive regulation of muscle tissue development |
| GO:2000725 | 0.02188 | 5.33240 | 1 | 3 | 48 | regulation of cardiac muscle cell differentiation |
| GO:0030030 | 0.02222 | 1.54535 | 20 | 29 | 1572 | cell projection organization |
| GO:0022613 | 0.02235 | 2.07946 | 5 | 11 | 439 | ribonucleoprotein complex biogenesis |
| GO:0070848 | 0.02267 | 1.89067 | 8 | 14 | 615 | response to growth factor |
| GO:0035556 | 0.02272 | 1.42588 | 32 | 44 | 2608 | intracellular signal transduction |
| GO:0051101 | 0.02283 | 3.23674 | 2 | 5 | 129 | regulation of DNA binding |
| GO:0043408 | 0.02292 | 1.80458 | 9 | 16 | 737 | regulation of MAPK cascade |
| GO:0032095 | 0.02298 | 9.38881 | 0 | 2 | 19 | regulation of response to food |
| GO:0033617 | 0.02298 | 9.38881 | 0 | 2 | 19 | mitochondrial respiratory chain complex IV assembly |
| GO:0035930 | 0.02298 | 9.38881 | 0 | 2 | 19 | corticosteroid hormone secretion |
| GO:0046827 | 0.02298 | 9.38881 | 0 | 2 | 19 | positive regulation of protein export from nucleus |
| GO:1902236 | 0.02298 | 9.38881 | 0 | 2 | 19 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:1902259 | 0.02298 | 9.38881 | 0 | 2 | 19 | regulation of delayed rectifier potassium channel activity |
| GO:1904754 | 0.02298 | 9.38881 | 0 | 2 | 19 | positive regulation of vascular associated smooth muscle cell migration |
| GO:0033173 | 0.02310 | 5.21625 | 1 | 3 | 49 | calcineurin-NFAT signaling cascade |
| GO:0051955 | 0.02310 | 5.21625 | 1 | 3 | 49 | regulation of amino acid transport |
| GO:0016202 | 0.02319 | 2.83737 | 2 | 6 | 176 | regulation of striated muscle tissue development |
| GO:0048878 | 0.02334 | 1.62353 | 15 | 23 | 1182 | chemical homeostasis |
| GO:0002690 | 0.02341 | 3.86185 | 1 | 4 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0044257 | 0.02368 | 1.79686 | 9 | 16 | 740 | cellular protein catabolic process |
| GO:0070201 | 0.02368 | 1.79686 | 9 | 16 | 740 | regulation of establishment of protein localization |
| GO:0010721 | 0.02384 | 2.14331 | 5 | 10 | 387 | negative regulation of cell development |
| GO:0033036 | 0.02400 | 1.40096 | 36 | 48 | 2901 | macromolecule localization |
| GO:0032642 | 0.02430 | 3.81571 | 1 | 4 | 88 | regulation of chemokine production |
| GO:0051149 | 0.02430 | 3.81571 | 1 | 4 | 88 | positive regulation of muscle cell differentiation |
| GO:0061136 | 0.02434 | 2.80413 | 2 | 6 | 178 | regulation of proteasomal protein catabolic process |
| GO:0045981 | 0.02435 | 5.10504 | 1 | 3 | 50 | positive regulation of nucleotide metabolic process |
| GO:0099054 | 0.02435 | 5.10504 | 1 | 3 | 50 | presynapse assembly |
| GO:1900544 | 0.02435 | 5.10504 | 1 | 3 | 50 | positive regulation of purine nucleotide metabolic process |
| GO:0001544 | 0.02475 | 79.58333 | 0 | 1 | 2 | initiation of primordial ovarian follicle growth |
| GO:0001971 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of activation of membrane attack complex |
| GO:0003050 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
| GO:0009203 | 0.02475 | 79.58333 | 0 | 1 | 2 | ribonucleoside triphosphate catabolic process |
| GO:0009441 | 0.02475 | 79.58333 | 0 | 1 | 2 | glycolate metabolic process |
| GO:0016098 | 0.02475 | 79.58333 | 0 | 1 | 2 | monoterpenoid metabolic process |
| GO:0016107 | 0.02475 | 79.58333 | 0 | 1 | 2 | sesquiterpenoid catabolic process |
| GO:0016487 | 0.02475 | 79.58333 | 0 | 1 | 2 | farnesol metabolic process |
| GO:0016488 | 0.02475 | 79.58333 | 0 | 1 | 2 | farnesol catabolic process |
| GO:0017186 | 0.02475 | 79.58333 | 0 | 1 | 2 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase |
| GO:0018008 | 0.02475 | 79.58333 | 0 | 1 | 2 | N-terminal peptidyl-glycine N-myristoylation |
| GO:0018307 | 0.02475 | 79.58333 | 0 | 1 | 2 | enzyme active site formation |
| GO:0018960 | 0.02475 | 79.58333 | 0 | 1 | 2 | 4-nitrophenol metabolic process |
| GO:0019043 | 0.02475 | 79.58333 | 0 | 1 | 2 | establishment of viral latency |
| GO:0019085 | 0.02475 | 79.58333 | 0 | 1 | 2 | early viral transcription |
| GO:0030474 | 0.02475 | 79.58333 | 0 | 1 | 2 | spindle pole body duplication |
| GO:0034117 | 0.02475 | 79.58333 | 0 | 1 | 2 | erythrocyte aggregation |
| GO:0034118 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of erythrocyte aggregation |
| GO:0034439 | 0.02475 | 79.58333 | 0 | 1 | 2 | lipoprotein lipid oxidation |
| GO:0034442 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of lipoprotein oxidation |
| GO:0035332 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of hippo signaling |
| GO:0036482 | 0.02475 | 79.58333 | 0 | 1 | 2 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide |
| GO:0042160 | 0.02475 | 79.58333 | 0 | 1 | 2 | lipoprotein modification |
| GO:0042161 | 0.02475 | 79.58333 | 0 | 1 | 2 | lipoprotein oxidation |
| GO:0042371 | 0.02475 | 79.58333 | 0 | 1 | 2 | vitamin K biosynthetic process |
| GO:0045728 | 0.02475 | 79.58333 | 0 | 1 | 2 | respiratory burst after phagocytosis |
| GO:0050787 | 0.02475 | 79.58333 | 0 | 1 | 2 | detoxification of mercury ion |
| GO:0051300 | 0.02475 | 79.58333 | 0 | 1 | 2 | spindle pole body organization |
| GO:0060587 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of lipoprotein lipid oxidation |
| GO:0061386 | 0.02475 | 79.58333 | 0 | 1 | 2 | closure of optic fissure |
| GO:0061760 | 0.02475 | 79.58333 | 0 | 1 | 2 | antifungal innate immune response |
| GO:0070171 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of tooth mineralization |
| GO:0070901 | 0.02475 | 79.58333 | 0 | 1 | 2 | mitochondrial tRNA methylation |
| GO:0071389 | 0.02475 | 79.58333 | 0 | 1 | 2 | cellular response to mineralocorticoid stimulus |
| GO:0071874 | 0.02475 | 79.58333 | 0 | 1 | 2 | cellular response to norepinephrine stimulus |
| GO:0090088 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of oligopeptide transport |
| GO:0090089 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of dipeptide transport |
| GO:0097166 | 0.02475 | 79.58333 | 0 | 1 | 2 | lens epithelial cell proliferation |
| GO:0097238 | 0.02475 | 79.58333 | 0 | 1 | 2 | cellular response to methylglyoxal |
| GO:0097639 | 0.02475 | 79.58333 | 0 | 1 | 2 | L-lysine import across plasma membrane |
| GO:1900142 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of oligodendrocyte apoptotic process |
| GO:1900240 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of phenotypic switching |
| GO:1903094 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of protein K48-linked deubiquitination |
| GO:1903383 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway |
| GO:1903384 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway |
| GO:1903632 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of aminoacyl-tRNA ligase activity |
| GO:1904046 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of vascular endothelial growth factor production |
| GO:1904397 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of neuromuscular junction development |
| GO:1904674 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of somatic stem cell population maintenance |
| GO:1904691 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of type B pancreatic cell proliferation |
| GO:1904782 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of NMDA glutamate receptor activity |
| GO:1905258 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway |
| GO:1905259 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway |
| GO:1905912 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of calcium ion export across plasma membrane |
| GO:1905916 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of cell differentiation involved in phenotypic switching |
| GO:1905931 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:2000098 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000157 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of ubiquitin-specific protease activity |
| GO:2000277 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of oxidative phosphorylation uncoupler activity |
| GO:2000282 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of cellular amino acid biosynthetic process |
| GO:2000469 | 0.02475 | 79.58333 | 0 | 1 | 2 | negative regulation of peroxidase activity |
| GO:2000724 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of cardiac vascular smooth muscle cell differentiation |
| GO:2000742 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of anterior head development |
| GO:2000744 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of anterior head development |
| GO:2000845 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of testosterone secretion |
| GO:2000878 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of oligopeptide transport |
| GO:2000880 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of dipeptide transport |
| GO:2001109 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of lens epithelial cell proliferation |
| GO:2001111 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of lens epithelial cell proliferation |
| GO:2001148 | 0.02475 | 79.58333 | 0 | 1 | 2 | regulation of dipeptide transmembrane transport |
| GO:2001150 | 0.02475 | 79.58333 | 0 | 1 | 2 | positive regulation of dipeptide transmembrane transport |
| GO:0008219 | 0.02491 | 1.46514 | 26 | 36 | 2065 | cell death |
| GO:0030177 | 0.02491 | 3.15986 | 2 | 5 | 132 | positive regulation of Wnt signaling pathway |
| GO:0034767 | 0.02494 | 2.78780 | 2 | 6 | 179 | positive regulation of ion transmembrane transport |
| GO:1901861 | 0.02494 | 2.78780 | 2 | 6 | 179 | regulation of muscle tissue development |
| GO:1901564 | 0.02498 | 1.29652 | 78 | 93 | 6234 | organonitrogen compound metabolic process |
| GO:0097191 | 0.02506 | 2.53806 | 3 | 7 | 229 | extrinsic apoptotic signaling pathway |
| GO:0051171 | 0.02507 | 1.31620 | 64 | 78 | 5104 | regulation of nitrogen compound metabolic process |
| GO:1900076 | 0.02520 | 3.77065 | 1 | 4 | 89 | regulation of cellular response to insulin stimulus |
| GO:1904035 | 0.02520 | 3.77065 | 1 | 4 | 89 | regulation of epithelial cell apoptotic process |
| GO:0098771 | 0.02527 | 1.78160 | 9 | 16 | 746 | inorganic ion homeostasis |
| GO:0032148 | 0.02533 | 8.86682 | 0 | 2 | 20 | activation of protein kinase B activity |
| GO:1900409 | 0.02533 | 8.86682 | 0 | 2 | 20 | positive regulation of cellular response to oxidative stress |
| GO:0043900 | 0.02536 | 2.12043 | 5 | 10 | 391 | regulation of multi-organism process |
| GO:0048634 | 0.02554 | 2.77166 | 2 | 6 | 180 | regulation of muscle organ development |
| GO:0034763 | 0.02563 | 3.13504 | 2 | 5 | 133 | negative regulation of transmembrane transport |
| GO:0003012 | 0.02575 | 2.11479 | 5 | 10 | 392 | muscle system process |
| GO:0055082 | 0.02580 | 1.74401 | 10 | 17 | 810 | cellular chemical homeostasis |
| GO:0050768 | 0.02597 | 2.21404 | 4 | 9 | 337 | negative regulation of neurogenesis |
| GO:0048870 | 0.02630 | 1.52101 | 20 | 29 | 1595 | cell motility |
| GO:0051674 | 0.02630 | 1.52101 | 20 | 29 | 1595 | localization of cell |
| GO:0050801 | 0.02633 | 1.73947 | 10 | 17 | 812 | ion homeostasis |
| GO:0055123 | 0.02637 | 3.11060 | 2 | 5 | 134 | digestive system development |
| GO:0034762 | 0.02647 | 1.89815 | 7 | 13 | 568 | regulation of transmembrane transport |
| GO:0050808 | 0.02654 | 2.02167 | 6 | 11 | 451 | synapse organization |
| GO:0001662 | 0.02697 | 4.89625 | 1 | 3 | 52 | behavioral fear response |
| GO:0097720 | 0.02697 | 4.89625 | 1 | 3 | 52 | calcineurin-mediated signaling |
| GO:2000677 | 0.02697 | 4.89625 | 1 | 3 | 52 | regulation of transcription regulatory region DNA binding |
| GO:1902533 | 0.02707 | 1.65577 | 13 | 20 | 1005 | positive regulation of intracellular signal transduction |
| GO:0006954 | 0.02712 | 1.80147 | 9 | 15 | 691 | inflammatory response |
| GO:0030278 | 0.02720 | 2.49270 | 3 | 7 | 233 | regulation of ossification |
| GO:0055085 | 0.02722 | 1.58082 | 16 | 24 | 1266 | transmembrane transport |
| GO:1901342 | 0.02773 | 2.18697 | 4 | 9 | 341 | regulation of vasculature development |
| GO:0010560 | 0.02776 | 8.39978 | 0 | 2 | 21 | positive regulation of glycoprotein biosynthetic process |
| GO:0019430 | 0.02776 | 8.39978 | 0 | 2 | 21 | removal of superoxide radicals |
| GO:0032682 | 0.02776 | 8.39978 | 0 | 2 | 21 | negative regulation of chemokine production |
| GO:0032930 | 0.02776 | 8.39978 | 0 | 2 | 21 | positive regulation of superoxide anion generation |
| GO:1901017 | 0.02776 | 8.39978 | 0 | 2 | 21 | negative regulation of potassium ion transmembrane transporter activity |
| GO:1901626 | 0.02776 | 8.39978 | 0 | 2 | 21 | regulation of postsynaptic membrane organization |
| GO:0001816 | 0.02781 | 1.75919 | 9 | 16 | 755 | cytokine production |
| GO:0016049 | 0.02792 | 1.93865 | 6 | 12 | 513 | cell growth |
| GO:0032602 | 0.02802 | 3.64163 | 1 | 4 | 92 | chemokine production |
| GO:0002209 | 0.02833 | 4.79811 | 1 | 3 | 53 | behavioral defense response |
| GO:0072593 | 0.02843 | 2.30208 | 4 | 8 | 288 | reactive oxygen species metabolic process |
| GO:1905475 | 0.02935 | 2.67856 | 2 | 6 | 186 | regulation of protein localization to membrane |
| GO:0009719 | 0.02946 | 1.53957 | 18 | 26 | 1409 | response to endogenous stimulus |
| GO:0051241 | 0.02962 | 1.55215 | 17 | 25 | 1343 | negative regulation of multicellular organismal process |
| GO:0010498 | 0.02964 | 1.98486 | 6 | 11 | 459 | proteasomal protein catabolic process |
| GO:0046718 | 0.02973 | 4.70383 | 1 | 3 | 54 | viral entry into host cell |
| GO:0040011 | 0.02974 | 1.47435 | 23 | 32 | 1817 | locomotion |
| GO:0002181 | 0.03001 | 3.56039 | 1 | 4 | 94 | cytoplasmic translation |
| GO:0006473 | 0.03001 | 2.66365 | 2 | 6 | 187 | protein acetylation |
| GO:0008535 | 0.03029 | 7.97944 | 0 | 2 | 22 | respiratory chain complex IV assembly |
| GO:0010996 | 0.03029 | 7.97944 | 0 | 2 | 22 | response to auditory stimulus |
| GO:0031643 | 0.03029 | 7.97944 | 0 | 2 | 22 | positive regulation of myelination |
| GO:0032098 | 0.03029 | 7.97944 | 0 | 2 | 22 | regulation of appetite |
| GO:0032691 | 0.03029 | 7.97944 | 0 | 2 | 22 | negative regulation of interleukin-1 beta production |
| GO:0032897 | 0.03029 | 7.97944 | 0 | 2 | 22 | negative regulation of viral transcription |
| GO:0046823 | 0.03029 | 7.97944 | 0 | 2 | 22 | negative regulation of nucleocytoplasmic transport |
| GO:2000353 | 0.03029 | 7.97944 | 0 | 2 | 22 | positive regulation of endothelial cell apoptotic process |
| GO:0010001 | 0.03063 | 2.42760 | 3 | 7 | 239 | glial cell differentiation |
| GO:1903362 | 0.03063 | 2.42760 | 3 | 7 | 239 | regulation of cellular protein catabolic process |
| GO:1905114 | 0.03091 | 1.90750 | 6 | 12 | 521 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0046888 | 0.03103 | 3.52111 | 1 | 4 | 95 | negative regulation of hormone secretion |
| GO:0048477 | 0.03103 | 3.52111 | 1 | 4 | 95 | oogenesis |
| GO:0050921 | 0.03104 | 2.97157 | 2 | 5 | 140 | positive regulation of chemotaxis |
| GO:0007528 | 0.03116 | 4.61317 | 1 | 3 | 55 | neuromuscular junction development |
| GO:0070887 | 0.03136 | 1.36937 | 38 | 49 | 3023 | cellular response to chemical stimulus |
| GO:0006725 | 0.03192 | 1.30008 | 62 | 76 | 5012 | cellular aromatic compound metabolic process |
| GO:0007588 | 0.03263 | 4.52593 | 1 | 3 | 56 | excretion |
| GO:0031641 | 0.03263 | 4.52593 | 1 | 3 | 56 | regulation of myelination |
| GO:0042596 | 0.03263 | 4.52593 | 1 | 3 | 56 | fear response |
| GO:0045667 | 0.03271 | 2.92793 | 2 | 5 | 142 | regulation of osteoblast differentiation |
| GO:0051130 | 0.03287 | 1.54914 | 16 | 24 | 1290 | positive regulation of cellular component organization |
| GO:0010663 | 0.03291 | 7.59914 | 0 | 2 | 23 | positive regulation of striated muscle cell apoptotic process |
| GO:0071450 | 0.03291 | 7.59914 | 0 | 2 | 23 | cellular response to oxygen radical |
| GO:0071451 | 0.03291 | 7.59914 | 0 | 2 | 23 | cellular response to superoxide |
| GO:1902884 | 0.03291 | 7.59914 | 0 | 2 | 23 | positive regulation of response to oxidative stress |
| GO:1903020 | 0.03291 | 7.59914 | 0 | 2 | 23 | positive regulation of glycoprotein metabolic process |
| GO:2000831 | 0.03291 | 7.59914 | 0 | 2 | 23 | regulation of steroid hormone secretion |
| GO:0090304 | 0.03327 | 1.31501 | 53 | 66 | 4277 | nucleic acid metabolic process |
| GO:0080090 | 0.03336 | 1.29196 | 65 | 79 | 5248 | regulation of primary metabolic process |
| GO:0010634 | 0.03356 | 2.90659 | 2 | 5 | 143 | positive regulation of epithelial cell migration |
| GO:0031323 | 0.03367 | 1.28839 | 67 | 81 | 5401 | regulation of cellular metabolic process |
| GO:0051649 | 0.03385 | 1.44860 | 24 | 33 | 1906 | establishment of localization in cell |
| GO:0048016 | 0.03414 | 4.44192 | 1 | 3 | 57 | inositol phosphate-mediated signaling |
| GO:0099172 | 0.03414 | 4.44192 | 1 | 3 | 57 | presynapse organization |
| GO:0032869 | 0.03424 | 2.57750 | 2 | 6 | 193 | cellular response to insulin stimulus |
| GO:0048771 | 0.03424 | 2.57750 | 2 | 6 | 193 | tissue remodeling |
| GO:0055002 | 0.03424 | 2.57750 | 2 | 6 | 193 | striated muscle cell development |
| GO:0009056 | 0.03430 | 1.41242 | 28 | 38 | 2257 | catabolic process |
| GO:0030001 | 0.03436 | 1.68028 | 10 | 17 | 839 | metal ion transport |
| GO:0002687 | 0.03443 | 2.88555 | 2 | 5 | 144 | positive regulation of leukocyte migration |
| GO:0007613 | 0.03443 | 2.88555 | 2 | 5 | 144 | memory |
| GO:0006469 | 0.03498 | 2.56368 | 2 | 6 | 194 | negative regulation of protein kinase activity |
| GO:0019941 | 0.03519 | 1.81751 | 7 | 13 | 592 | modification-dependent protein catabolic process |
| GO:0031099 | 0.03531 | 2.86481 | 2 | 5 | 145 | regeneration |
| GO:0032755 | 0.03533 | 3.37226 | 1 | 4 | 99 | positive regulation of interleukin-6 production |
| GO:0033555 | 0.03533 | 3.37226 | 1 | 4 | 99 | multicellular organismal response to stress |
| GO:0032928 | 0.03561 | 7.25341 | 0 | 2 | 24 | regulation of superoxide anion generation |
| GO:0035813 | 0.03561 | 7.25341 | 0 | 2 | 24 | regulation of renal sodium excretion |
| GO:0043496 | 0.03561 | 7.25341 | 0 | 2 | 24 | regulation of protein homodimerization activity |
| GO:0043921 | 0.03561 | 7.25341 | 0 | 2 | 24 | modulation by host of viral transcription |
| GO:0052312 | 0.03561 | 7.25341 | 0 | 2 | 24 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0052472 | 0.03561 | 7.25341 | 0 | 2 | 24 | modulation by host of symbiont transcription |
| GO:0098869 | 0.03561 | 7.25341 | 0 | 2 | 24 | cellular oxidant detoxification |
| GO:1901984 | 0.03561 | 7.25341 | 0 | 2 | 24 | negative regulation of protein acetylation |
| GO:0010656 | 0.03568 | 4.36097 | 1 | 3 | 58 | negative regulation of muscle cell apoptotic process |
| GO:0010662 | 0.03568 | 4.36097 | 1 | 3 | 58 | regulation of striated muscle cell apoptotic process |
| GO:0030260 | 0.03568 | 4.36097 | 1 | 3 | 58 | entry into host cell |
| GO:0044409 | 0.03568 | 4.36097 | 1 | 3 | 58 | entry into host |
| GO:0051806 | 0.03568 | 4.36097 | 1 | 3 | 58 | entry into cell of other organism involved in symbiotic interaction |
| GO:0051828 | 0.03568 | 4.36097 | 1 | 3 | 58 | entry into other organism involved in symbiotic interaction |
| GO:0030307 | 0.03573 | 2.55000 | 2 | 6 | 195 | positive regulation of cell growth |
| GO:0061024 | 0.03584 | 1.69971 | 10 | 16 | 780 | membrane organization |
| GO:0046883 | 0.03611 | 2.19111 | 4 | 8 | 302 | regulation of hormone secretion |
| GO:0032880 | 0.03613 | 1.59968 | 13 | 20 | 1038 | regulation of protein localization |
| GO:0043412 | 0.03634 | 1.32866 | 45 | 57 | 3634 | macromolecule modification |
| GO:0055013 | 0.03645 | 3.33699 | 1 | 4 | 100 | cardiac muscle cell development |
| GO:0000710 | 0.03689 | 39.78993 | 0 | 1 | 3 | meiotic mismatch repair |
| GO:0001543 | 0.03689 | 39.78993 | 0 | 1 | 3 | ovarian follicle rupture |
| GO:0002019 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of renal output by angiotensin |
| GO:0002933 | 0.03689 | 39.78993 | 0 | 1 | 3 | lipid hydroxylation |
| GO:0003051 | 0.03689 | 39.78993 | 0 | 1 | 3 | angiotensin-mediated drinking behavior |
| GO:0003331 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of extracellular matrix constituent secretion |
| GO:0006295 | 0.03689 | 39.78993 | 0 | 1 | 3 | nucleotide-excision repair, DNA incision, 3'-to lesion |
| GO:0006296 | 0.03689 | 39.78993 | 0 | 1 | 3 | nucleotide-excision repair, DNA incision, 5'-to lesion |
| GO:0006714 | 0.03689 | 39.78993 | 0 | 1 | 3 | sesquiterpenoid metabolic process |
| GO:0006990 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response |
| GO:0007403 | 0.03689 | 39.78993 | 0 | 1 | 3 | glial cell fate determination |
| GO:0009298 | 0.03689 | 39.78993 | 0 | 1 | 3 | GDP-mannose biosynthetic process |
| GO:0010963 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of L-arginine import |
| GO:0014737 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of muscle atrophy |
| GO:0016095 | 0.03689 | 39.78993 | 0 | 1 | 3 | polyprenol catabolic process |
| GO:0017187 | 0.03689 | 39.78993 | 0 | 1 | 3 | peptidyl-glutamic acid carboxylation |
| GO:0018199 | 0.03689 | 39.78993 | 0 | 1 | 3 | peptidyl-glutamine modification |
| GO:0019045 | 0.03689 | 39.78993 | 0 | 1 | 3 | latent virus replication |
| GO:0019046 | 0.03689 | 39.78993 | 0 | 1 | 3 | release from viral latency |
| GO:0019086 | 0.03689 | 39.78993 | 0 | 1 | 3 | late viral transcription |
| GO:0031104 | 0.03689 | 39.78993 | 0 | 1 | 3 | dendrite regeneration |
| GO:0034199 | 0.03689 | 39.78993 | 0 | 1 | 3 | activation of protein kinase A activity |
| GO:0034371 | 0.03689 | 39.78993 | 0 | 1 | 3 | chylomicron remodeling |
| GO:0035442 | 0.03689 | 39.78993 | 0 | 1 | 3 | dipeptide transmembrane transport |
| GO:0035928 | 0.03689 | 39.78993 | 0 | 1 | 3 | rRNA import into mitochondrion |
| GO:0035936 | 0.03689 | 39.78993 | 0 | 1 | 3 | testosterone secretion |
| GO:0045329 | 0.03689 | 39.78993 | 0 | 1 | 3 | carnitine biosynthetic process |
| GO:0045764 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of cellular amino acid metabolic process |
| GO:0051595 | 0.03689 | 39.78993 | 0 | 1 | 3 | response to methylglyoxal |
| GO:0055095 | 0.03689 | 39.78993 | 0 | 1 | 3 | lipoprotein particle mediated signaling |
| GO:0055096 | 0.03689 | 39.78993 | 0 | 1 | 3 | low-density lipoprotein particle mediated signaling |
| GO:0060741 | 0.03689 | 39.78993 | 0 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0070488 | 0.03689 | 39.78993 | 0 | 1 | 3 | neutrophil aggregation |
| GO:0071873 | 0.03689 | 39.78993 | 0 | 1 | 3 | response to norepinephrine |
| GO:0090360 | 0.03689 | 39.78993 | 0 | 1 | 3 | platelet-derived growth factor production |
| GO:0090361 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of platelet-derived growth factor production |
| GO:0090679 | 0.03689 | 39.78993 | 0 | 1 | 3 | cell differentiation involved in phenotypic switching |
| GO:0097176 | 0.03689 | 39.78993 | 0 | 1 | 3 | epoxide metabolic process |
| GO:0097745 | 0.03689 | 39.78993 | 0 | 1 | 3 | mitochondrial tRNA 5'-end processing |
| GO:0099562 | 0.03689 | 39.78993 | 0 | 1 | 3 | maintenance of postsynaptic density structure |
| GO:1900141 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of oligodendrocyte apoptotic process |
| GO:1900450 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of glutamate receptor signaling pathway |
| GO:1901629 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of presynaptic membrane organization |
| GO:1901671 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of superoxide dismutase activity |
| GO:1902022 | 0.03689 | 39.78993 | 0 | 1 | 3 | L-lysine transport |
| GO:1902309 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of peptidyl-serine dephosphorylation |
| GO:1902488 | 0.03689 | 39.78993 | 0 | 1 | 3 | cholangiocyte apoptotic process |
| GO:1902511 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of apoptotic DNA fragmentation |
| GO:1902958 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:1903093 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of protein K48-linked deubiquitination |
| GO:1903179 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of dopamine biosynthetic process |
| GO:1903181 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of dopamine biosynthetic process |
| GO:1903401 | 0.03689 | 39.78993 | 0 | 1 | 3 | L-lysine transmembrane transport |
| GO:1903598 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of gap junction assembly |
| GO:1903630 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of aminoacyl-tRNA ligase activity |
| GO:1904192 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of cholangiocyte apoptotic process |
| GO:1904193 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of cholangiocyte apoptotic process |
| GO:1904339 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of dopaminergic neuron differentiation |
| GO:1904431 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of t-circle formation |
| GO:1904780 | 0.03689 | 39.78993 | 0 | 1 | 3 | negative regulation of protein localization to centrosome |
| GO:1904833 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of removal of superoxide radicals |
| GO:1905319 | 0.03689 | 39.78993 | 0 | 1 | 3 | mesenchymal stem cell migration |
| GO:1905320 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of mesenchymal stem cell migration |
| GO:1905322 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of mesenchymal stem cell migration |
| GO:1905420 | 0.03689 | 39.78993 | 0 | 1 | 3 | vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:1905915 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of cell differentiation involved in phenotypic switching |
| GO:1905930 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:1990180 | 0.03689 | 39.78993 | 0 | 1 | 3 | mitochondrial tRNA 3'-end processing |
| GO:1990442 | 0.03689 | 39.78993 | 0 | 1 | 3 | intrinsic apoptotic signaling pathway in response to nitrosative stress |
| GO:1990523 | 0.03689 | 39.78993 | 0 | 1 | 3 | bone regeneration |
| GO:2000152 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of ubiquitin-specific protease activity |
| GO:2000468 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of peroxidase activity |
| GO:2000722 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of cardiac vascular smooth muscle cell differentiation |
| GO:2000823 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of androgen receptor activity |
| GO:2000825 | 0.03689 | 39.78993 | 0 | 1 | 3 | positive regulation of androgen receptor activity |
| GO:2000843 | 0.03689 | 39.78993 | 0 | 1 | 3 | regulation of testosterone secretion |
| GO:0007029 | 0.03726 | 4.28290 | 1 | 3 | 59 | endoplasmic reticulum organization |
| GO:0010659 | 0.03726 | 4.28290 | 1 | 3 | 59 | cardiac muscle cell apoptotic process |
| GO:1901016 | 0.03726 | 4.28290 | 1 | 3 | 59 | regulation of potassium ion transmembrane transporter activity |
| GO:1903078 | 0.03726 | 4.28290 | 1 | 3 | 59 | positive regulation of protein localization to plasma membrane |
| GO:2001238 | 0.03726 | 4.28290 | 1 | 3 | 59 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0003300 | 0.03760 | 3.30244 | 1 | 4 | 101 | cardiac muscle hypertrophy |
| GO:0055024 | 0.03760 | 3.30244 | 1 | 4 | 101 | regulation of cardiac muscle tissue development |
| GO:0051961 | 0.03777 | 2.06089 | 4 | 9 | 361 | negative regulation of nervous system development |
| GO:0050657 | 0.03804 | 2.80434 | 2 | 5 | 148 | nucleic acid transport |
| GO:0050658 | 0.03804 | 2.80434 | 2 | 5 | 148 | RNA transport |
| GO:0048589 | 0.03836 | 1.68375 | 10 | 16 | 787 | developmental growth |
| GO:1901360 | 0.03837 | 1.28202 | 65 | 78 | 5208 | organic cyclic compound metabolic process |
| GO:0010640 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010742 | 0.03840 | 6.93774 | 0 | 2 | 25 | macrophage derived foam cell differentiation |
| GO:0032104 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of response to extracellular stimulus |
| GO:0032107 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of response to nutrient levels |
| GO:0032469 | 0.03840 | 6.93774 | 0 | 2 | 25 | endoplasmic reticulum calcium ion homeostasis |
| GO:0043171 | 0.03840 | 6.93774 | 0 | 2 | 25 | peptide catabolic process |
| GO:0043567 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0050832 | 0.03840 | 6.93774 | 0 | 2 | 25 | defense response to fungus |
| GO:0090280 | 0.03840 | 6.93774 | 0 | 2 | 25 | positive regulation of calcium ion import |
| GO:0150077 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of neuroinflammatory response |
| GO:1901032 | 0.03840 | 6.93774 | 0 | 2 | 25 | negative regulation of response to reactive oxygen species |
| GO:1901798 | 0.03840 | 6.93774 | 0 | 2 | 25 | positive regulation of signal transduction by p53 class mediator |
| GO:1903206 | 0.03840 | 6.93774 | 0 | 2 | 25 | negative regulation of hydrogen peroxide-induced cell death |
| GO:1904738 | 0.03840 | 6.93774 | 0 | 2 | 25 | vascular associated smooth muscle cell migration |
| GO:1904752 | 0.03840 | 6.93774 | 0 | 2 | 25 | regulation of vascular associated smooth muscle cell migration |
| GO:2000679 | 0.03840 | 6.93774 | 0 | 2 | 25 | positive regulation of transcription regulatory region DNA binding |
| GO:2001039 | 0.03840 | 6.93774 | 0 | 2 | 25 | negative regulation of cellular response to drug |
| GO:0044248 | 0.03840 | 1.42433 | 25 | 34 | 1996 | cellular catabolic process |
| GO:0046849 | 0.03877 | 3.26860 | 1 | 4 | 102 | bone remodeling |
| GO:0001649 | 0.03883 | 2.49671 | 2 | 6 | 199 | osteoblast differentiation |
| GO:0030522 | 0.03883 | 2.49671 | 2 | 6 | 199 | intracellular receptor signaling pathway |
| GO:0050679 | 0.03883 | 2.49671 | 2 | 6 | 199 | positive regulation of epithelial cell proliferation |
| GO:0051051 | 0.03893 | 1.83730 | 7 | 12 | 540 | negative regulation of transport |
| GO:0050728 | 0.03898 | 2.78475 | 2 | 5 | 149 | negative regulation of inflammatory response |
| GO:0010959 | 0.03899 | 1.96304 | 5 | 10 | 421 | regulation of metal ion transport |
| GO:0043632 | 0.03937 | 1.78586 | 7 | 13 | 602 | modification-dependent macromolecule catabolic process |
| GO:0045927 | 0.03979 | 2.14671 | 4 | 8 | 308 | positive regulation of growth |
| GO:0014013 | 0.03993 | 2.76542 | 2 | 5 | 150 | regulation of gliogenesis |
| GO:0034614 | 0.03993 | 2.76542 | 2 | 5 | 150 | cellular response to reactive oxygen species |
| GO:0035967 | 0.03995 | 3.23544 | 1 | 4 | 103 | cellular response to topologically incorrect protein |
| GO:0140053 | 0.03995 | 3.23544 | 1 | 4 | 103 | mitochondrial gene expression |
| GO:1903426 | 0.03995 | 3.23544 | 1 | 4 | 103 | regulation of reactive oxygen species biosynthetic process |
| GO:0046879 | 0.04004 | 2.03737 | 5 | 9 | 365 | hormone secretion |
| GO:0006508 | 0.04021 | 1.45884 | 21 | 29 | 1657 | proteolysis |
| GO:0015980 | 0.04044 | 2.27866 | 3 | 7 | 254 | energy derivation by oxidation of organic compounds |
| GO:0002685 | 0.04044 | 2.47089 | 3 | 6 | 201 | regulation of leukocyte migration |
| GO:0042058 | 0.04051 | 4.13486 | 1 | 3 | 61 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0042698 | 0.04051 | 4.13486 | 1 | 3 | 61 | ovulation cycle |
| GO:0045600 | 0.04051 | 4.13486 | 1 | 3 | 61 | positive regulation of fat cell differentiation |
| GO:1903428 | 0.04051 | 4.13486 | 1 | 3 | 61 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0009306 | 0.04069 | 1.77657 | 8 | 13 | 605 | protein secretion |
| GO:0006915 | 0.04088 | 1.43079 | 23 | 32 | 1867 | apoptotic process |
| GO:0030178 | 0.04089 | 2.74636 | 2 | 5 | 151 | negative regulation of Wnt signaling pathway |
| GO:0051236 | 0.04089 | 2.74636 | 2 | 5 | 151 | establishment of RNA localization |
| GO:0000303 | 0.04126 | 6.64837 | 0 | 2 | 26 | response to superoxide |
| GO:0033688 | 0.04126 | 6.64837 | 0 | 2 | 26 | regulation of osteoblast proliferation |
| GO:0035812 | 0.04126 | 6.64837 | 0 | 2 | 26 | renal sodium excretion |
| GO:0035929 | 0.04126 | 6.64837 | 0 | 2 | 26 | steroid hormone secretion |
| GO:0045742 | 0.04126 | 6.64837 | 0 | 2 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0050927 | 0.04126 | 6.64837 | 0 | 2 | 26 | positive regulation of positive chemotaxis |
| GO:0089718 | 0.04126 | 6.64837 | 0 | 2 | 26 | amino acid import across plasma membrane |
| GO:0090077 | 0.04126 | 6.64837 | 0 | 2 | 26 | foam cell differentiation |
| GO:1901380 | 0.04126 | 6.64837 | 0 | 2 | 26 | negative regulation of potassium ion transmembrane transport |
| GO:2000738 | 0.04126 | 6.64837 | 0 | 2 | 26 | positive regulation of stem cell differentiation |
| GO:0120036 | 0.04186 | 1.47272 | 19 | 27 | 1526 | plasma membrane bounded cell projection organization |
| GO:0046661 | 0.04187 | 2.72756 | 2 | 5 | 152 | male sex differentiation |
| GO:0006367 | 0.04219 | 4.06460 | 1 | 3 | 62 | transcription initiation from RNA polymerase II promoter |
| GO:0006721 | 0.04219 | 4.06460 | 1 | 3 | 62 | terpenoid metabolic process |
| GO:0015800 | 0.04219 | 4.06460 | 1 | 3 | 62 | acidic amino acid transport |
| GO:0043949 | 0.04219 | 4.06460 | 1 | 3 | 62 | regulation of cAMP-mediated signaling |
| GO:0048008 | 0.04219 | 4.06460 | 1 | 3 | 62 | platelet-derived growth factor receptor signaling pathway |
| GO:0086003 | 0.04219 | 4.06460 | 1 | 3 | 62 | cardiac muscle cell contraction |
| GO:0007267 | 0.04229 | 1.46093 | 20 | 28 | 1596 | cell-cell signaling |
| GO:0014897 | 0.04239 | 3.17110 | 1 | 4 | 105 | striated muscle hypertrophy |
| GO:1901566 | 0.04313 | 1.45794 | 20 | 28 | 1599 | organonitrogen compound biosynthetic process |
| GO:0006464 | 0.04336 | 1.31977 | 43 | 54 | 3453 | cellular protein modification process |
| GO:0036211 | 0.04336 | 1.31977 | 43 | 54 | 3453 | protein modification process |
| GO:0010605 | 0.04343 | 1.36320 | 32 | 42 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0019359 | 0.04363 | 3.13987 | 1 | 4 | 106 | nicotinamide nucleotide biosynthetic process |
| GO:0045185 | 0.04363 | 3.13987 | 1 | 4 | 106 | maintenance of protein location |
| GO:0055006 | 0.04363 | 3.13987 | 1 | 4 | 106 | cardiac cell development |
| GO:0019725 | 0.04373 | 1.60291 | 12 | 18 | 930 | cellular homeostasis |
| GO:0042325 | 0.04387 | 1.46540 | 19 | 27 | 1533 | regulation of phosphorylation |
| GO:0050708 | 0.04406 | 1.85385 | 6 | 11 | 490 | regulation of protein secretion |
| GO:0000305 | 0.04421 | 6.38216 | 0 | 2 | 27 | response to oxygen radical |
| GO:0018195 | 0.04421 | 6.38216 | 0 | 2 | 27 | peptidyl-arginine modification |
| GO:0050926 | 0.04421 | 6.38216 | 0 | 2 | 27 | regulation of positive chemotaxis |
| GO:0051354 | 0.04421 | 6.38216 | 0 | 2 | 27 | negative regulation of oxidoreductase activity |
| GO:0043062 | 0.04439 | 2.09712 | 4 | 8 | 315 | extracellular structure organization |
| GO:0009914 | 0.04486 | 1.99189 | 5 | 9 | 373 | hormone transport |
| GO:0048588 | 0.04488 | 2.22403 | 3 | 7 | 260 | developmental cell growth |
| GO:0048738 | 0.04488 | 2.22403 | 3 | 7 | 260 | cardiac muscle tissue development |
| GO:0003014 | 0.04490 | 3.10925 | 1 | 4 | 107 | renal system process |
| GO:0009185 | 0.04490 | 3.10925 | 1 | 4 | 107 | ribonucleoside diphosphate metabolic process |
| GO:0014896 | 0.04490 | 3.10925 | 1 | 4 | 107 | muscle hypertrophy |
| GO:0048145 | 0.04490 | 3.10925 | 1 | 4 | 107 | regulation of fibroblast proliferation |
| GO:0031324 | 0.04528 | 1.36783 | 30 | 40 | 2449 | negative regulation of cellular metabolic process |
| GO:0034613 | 0.04543 | 1.44072 | 21 | 29 | 1676 | cellular protein localization |
| GO:0055001 | 0.04553 | 2.39650 | 3 | 6 | 207 | muscle cell development |
| GO:0034605 | 0.04566 | 3.93099 | 1 | 3 | 64 | cellular response to heat |
| GO:0046824 | 0.04566 | 3.93099 | 1 | 3 | 64 | positive regulation of nucleocytoplasmic transport |
| GO:0051926 | 0.04566 | 3.93099 | 1 | 3 | 64 | negative regulation of calcium ion transport |
| GO:1903391 | 0.04566 | 3.93099 | 1 | 3 | 64 | regulation of adherens junction organization |
| GO:2000736 | 0.04566 | 3.93099 | 1 | 3 | 64 | regulation of stem cell differentiation |
| GO:0051302 | 0.04593 | 2.65484 | 2 | 5 | 156 | regulation of cell division |
| GO:0071383 | 0.04593 | 2.65484 | 2 | 5 | 156 | cellular response to steroid hormone stimulus |
| GO:0030316 | 0.04619 | 3.07922 | 1 | 4 | 108 | osteoclast differentiation |
| GO:0051028 | 0.04619 | 3.07922 | 1 | 4 | 108 | mRNA transport |
| GO:0048193 | 0.04721 | 2.19768 | 3 | 7 | 263 | Golgi vesicle transport |
| GO:0051957 | 0.04722 | 6.13642 | 0 | 2 | 28 | positive regulation of amino acid transport |
| GO:0061050 | 0.04722 | 6.13642 | 0 | 2 | 28 | regulation of cell growth involved in cardiac muscle cell development |
| GO:1901186 | 0.04722 | 6.13642 | 0 | 2 | 28 | positive regulation of ERBB signaling pathway |
| GO:0010817 | 0.04727 | 1.77864 | 7 | 12 | 557 | regulation of hormone levels |
| GO:0017038 | 0.04731 | 2.37268 | 3 | 6 | 209 | protein import |
| GO:0150076 | 0.04744 | 3.86741 | 1 | 3 | 65 | neuroinflammatory response |
| GO:0019363 | 0.04750 | 3.04976 | 1 | 4 | 109 | pyridine nucleotide biosynthetic process |
| GO:0048144 | 0.04750 | 3.04976 | 1 | 4 | 109 | fibroblast proliferation |
| GO:2000379 | 0.04750 | 3.04976 | 1 | 4 | 109 | positive regulation of reactive oxygen species metabolic process |
| GO:0032446 | 0.04777 | 1.73150 | 8 | 13 | 620 | protein modification by small protein conjugation |
| GO:0009755 | 0.04804 | 2.61990 | 2 | 5 | 158 | hormone-mediated signaling pathway |
| GO:0046496 | 0.04804 | 2.61990 | 2 | 5 | 158 | nicotinamide nucleotide metabolic process |
| GO:0010941 | 0.04807 | 1.43229 | 21 | 29 | 1685 | regulation of cell death |
| GO:0001932 | 0.04810 | 1.47249 | 18 | 25 | 1410 | regulation of protein phosphorylation |
| GO:0044271 | 0.04813 | 1.29206 | 50 | 61 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0070727 | 0.04837 | 1.43135 | 21 | 29 | 1686 | cellular macromolecule localization |
| GO:0006091 | 0.04872 | 1.95906 | 5 | 9 | 379 | generation of precursor metabolites and energy |
| GO:0042593 | 0.04881 | 2.18045 | 3 | 7 | 265 | glucose homeostasis |
| GO:0000320 | 0.04889 | 26.52546 | 0 | 1 | 4 | re-entry into mitotic cell cycle |
| GO:0000720 | 0.04889 | 26.52546 | 0 | 1 | 4 | pyrimidine dimer repair by nucleotide-excision repair |
| GO:0000964 | 0.04889 | 26.52546 | 0 | 1 | 4 | mitochondrial RNA 5'-end processing |
| GO:0001732 | 0.04889 | 26.52546 | 0 | 1 | 4 | formation of cytoplasmic translation initiation complex |
| GO:0001905 | 0.04889 | 26.52546 | 0 | 1 | 4 | activation of membrane attack complex |
| GO:0001969 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of activation of membrane attack complex |
| GO:0001998 | 0.04889 | 26.52546 | 0 | 1 | 4 | angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0002018 | 0.04889 | 26.52546 | 0 | 1 | 4 | renin-angiotensin regulation of aldosterone production |
| GO:0006499 | 0.04889 | 26.52546 | 0 | 1 | 4 | N-terminal protein myristoylation |
| GO:0006578 | 0.04889 | 26.52546 | 0 | 1 | 4 | amino-acid betaine biosynthetic process |
| GO:0007525 | 0.04889 | 26.52546 | 0 | 1 | 4 | somatic muscle development |
| GO:0008065 | 0.04889 | 26.52546 | 0 | 1 | 4 | establishment of blood-nerve barrier |
| GO:0010536 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of activation of Janus kinase activity |
| GO:0015734 | 0.04889 | 26.52546 | 0 | 1 | 4 | taurine transport |
| GO:0018171 | 0.04889 | 26.52546 | 0 | 1 | 4 | peptidyl-cysteine oxidation |
| GO:0018201 | 0.04889 | 26.52546 | 0 | 1 | 4 | peptidyl-glycine modification |
| GO:0018214 | 0.04889 | 26.52546 | 0 | 1 | 4 | protein carboxylation |
| GO:0018377 | 0.04889 | 26.52546 | 0 | 1 | 4 | protein myristoylation |
| GO:0019042 | 0.04889 | 26.52546 | 0 | 1 | 4 | viral latency |
| GO:0019732 | 0.04889 | 26.52546 | 0 | 1 | 4 | antifungal humoral response |
| GO:0021886 | 0.04889 | 26.52546 | 0 | 1 | 4 | hypothalamus gonadotrophin-releasing hormone neuron differentiation |
| GO:0021888 | 0.04889 | 26.52546 | 0 | 1 | 4 | hypothalamus gonadotrophin-releasing hormone neuron development |
| GO:0030091 | 0.04889 | 26.52546 | 0 | 1 | 4 | protein repair |
| GO:0032849 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of cellular pH reduction |
| GO:0035672 | 0.04889 | 26.52546 | 0 | 1 | 4 | oligopeptide transmembrane transport |
| GO:0042938 | 0.04889 | 26.52546 | 0 | 1 | 4 | dipeptide transport |
| GO:0043152 | 0.04889 | 26.52546 | 0 | 1 | 4 | induction of bacterial agglutination |
| GO:0048200 | 0.04889 | 26.52546 | 0 | 1 | 4 | Golgi transport vesicle coating |
| GO:0048205 | 0.04889 | 26.52546 | 0 | 1 | 4 | COPI coating of Golgi vesicle |
| GO:0048936 | 0.04889 | 26.52546 | 0 | 1 | 4 | peripheral nervous system neuron axonogenesis |
| GO:0050748 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of lipoprotein metabolic process |
| GO:0055129 | 0.04889 | 26.52546 | 0 | 1 | 4 | L-proline biosynthetic process |
| GO:0060221 | 0.04889 | 26.52546 | 0 | 1 | 4 | retinal rod cell differentiation |
| GO:0060279 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of ovulation |
| GO:0061819 | 0.04889 | 26.52546 | 0 | 1 | 4 | telomeric DNA-containing double minutes formation |
| GO:0070294 | 0.04889 | 26.52546 | 0 | 1 | 4 | renal sodium ion absorption |
| GO:0070900 | 0.04889 | 26.52546 | 0 | 1 | 4 | mitochondrial tRNA modification |
| GO:0090086 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of protein deubiquitination |
| GO:0090290 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of osteoclast proliferation |
| GO:0097210 | 0.04889 | 26.52546 | 0 | 1 | 4 | response to gonadotropin-releasing hormone |
| GO:0097211 | 0.04889 | 26.52546 | 0 | 1 | 4 | cellular response to gonadotropin-releasing hormone |
| GO:0099183 | 0.04889 | 26.52546 | 0 | 1 | 4 | trans-synaptic signaling by BDNF, modulating synaptic transmission |
| GO:0099191 | 0.04889 | 26.52546 | 0 | 1 | 4 | trans-synaptic signaling by BDNF |
| GO:0099538 | 0.04889 | 26.52546 | 0 | 1 | 4 | synaptic signaling via neuropeptide |
| GO:1900864 | 0.04889 | 26.52546 | 0 | 1 | 4 | mitochondrial RNA modification |
| GO:1901300 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of hydrogen peroxide-mediated programmed cell death |
| GO:1901668 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of superoxide dismutase activity |
| GO:1902730 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of proteoglycan biosynthetic process |
| GO:1902956 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:1903121 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1903596 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of gap junction assembly |
| GO:1903625 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of DNA catabolic process |
| GO:1903750 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide |
| GO:1903751 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide |
| GO:1904207 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of chemokine (C-C motif) ligand 2 secretion |
| GO:1904209 | 0.04889 | 26.52546 | 0 | 1 | 4 | positive regulation of chemokine (C-C motif) ligand 2 secretion |
| GO:1905460 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of vascular associated smooth muscle cell apoptotic process |
| GO:1905553 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of blood vessel branching |
| GO:1905764 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of protection from non-homologous end joining at telomere |
| GO:1905765 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of protection from non-homologous end joining at telomere |
| GO:1905907 | 0.04889 | 26.52546 | 0 | 1 | 4 | negative regulation of amyloid fibril formation |
| GO:1990966 | 0.04889 | 26.52546 | 0 | 1 | 4 | ATP generation from poly-ADP-D-ribose |
| GO:2000097 | 0.04889 | 26.52546 | 0 | 1 | 4 | regulation of smooth muscle cell-matrix adhesion |
| GO:0010810 | 0.04914 | 2.34932 | 3 | 6 | 211 | regulation of cell-substrate adhesion |
| GO:0060047 | 0.04914 | 2.34932 | 3 | 6 | 211 | heart contraction |
| GO:1901184 | 0.04926 | 3.80586 | 1 | 3 | 66 | regulation of ERBB signaling pathway |
| GO:1904377 | 0.04926 | 3.80586 | 1 | 3 | 66 | positive regulation of protein localization to cell periphery |
| GO:0051235 | 0.04933 | 2.04973 | 4 | 8 | 322 | maintenance of location |
| GO:0033500 | 0.04962 | 2.17194 | 3 | 7 | 266 | carbohydrate homeostasis |
| GO:0031399 | 0.04972 | 1.41882 | 22 | 30 | 1760 | regulation of protein modification process |